[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fwPoXun8V6hyYvkBso6e93On6NeZaRMbjRUi0ef2hLuI":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":34,"phaseBuckets":84,"rows":91},"Helsinki University Central Hospital",[4],307,false,67,13,485519,41,230,[14,17,19,22,25,27,30,32],{"name":15,"count":16},"Obesity",7,{"name":18,"count":16},"Quality of Life",{"name":20,"count":21},"Critical Illness",6,{"name":23,"count":24},"Appendicitis",5,{"name":26,"count":24},"Surgery",{"name":28,"count":29},"Critically Ill",4,{"name":31,"count":29},"Pancreatic Cancer",{"name":33,"count":29},"Gestational Diabetes",[35,40,45,50,55,60,65,69,74,79],{"nctId":36,"briefTitle":37,"date":38,"intervention":39},"NCT02775227","HYPAR Trial - Hydrocortisone vs. Pasireotide in Reducing Pancreatic Surgery Complications","2019-01","Hydrocortisone",{"nctId":41,"briefTitle":42,"date":43,"intervention":44},"NCT04168346","Preoperative Intravenous Iron Therapy in Patients With Gastric Cancer","2021-11","Ferric carboxymaltose",{"nctId":46,"briefTitle":47,"date":48,"intervention":49},"NCT04281667","Mechanical Bowel Preparation and Oral Antibiotics Versus Mechanical Bowel Preparation Only Prior Rectal Surgery","2022-11-09","Oral Antibiotics",{"nctId":51,"briefTitle":52,"date":53,"intervention":54},"NCT05361785","Fecal Microbiota Transplantation for Irritable Bowel Syndrome Associated Food Intolerance","2024-07-31","FMT",{"nctId":56,"briefTitle":57,"date":58,"intervention":59},"NCT02625441","Adjuvant Trastuzumab, Pertuzumab Plus Docetaxel in the Treatment of Early HER2-positive Breast Cancer","2025-06-01","Pertuzumab",{"nctId":61,"briefTitle":62,"date":63,"intervention":64},"NCT05337566","Does Additional Use of Preoperative Azithromycin Decrease Posthysterectomy Infections","2025-12","Azithromycin Pill + Cefuroxime",{"nctId":66,"briefTitle":67,"date":63,"intervention":68},"NCT06155916","Sleep and Neuropathic Pain - Intervention Study on Pregabalin","Pregabalin",{"nctId":70,"briefTitle":71,"date":72,"intervention":73},"NCT05245877","Pre- Vs. Postoperative Thromboprophylaxis in Pancreatic Surgery","2026-08","enoxaparin\u002Ftinzaparin\u002Fdalteparin",{"nctId":75,"briefTitle":76,"date":77,"intervention":78},"NCT05159245","The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs","2026-11-25","Alectinib",{"nctId":80,"briefTitle":81,"date":82,"intervention":83},"NCT07462559","KF2025#1 Trial: Ketamine, Cannabidiol and Cobicistat Interaction Study","2026-12-31","Ketamine 10 mg\u002Fml oral solution, UK special",[85,86,87,88,89,90],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[92,119,137,164,190,219,237,266,284,315,342,360,384,409,431,449,474,511,529,547,565,583,601,619,637,655,673,691,709,727,745,763,790,813,831,849,874,899,923,948,971,995,1036,1062,1089,1107,1132,1158,1176,1200,1227,1245,1273,1291,1309,1338,1356,1379,1397,1424,1442,1472,1490,1517,1535,1561,1590,1608,1626,1644,1668,1694,1712,1738,1756,1784,1802,1827,1852,1870,1897,1915,1933,1959,1977,2003,2021,2048,2066,2084,2112,2137,2162,2191,2209,2227,2252,2278,2296,2321,2348,2366,2384,2402,2431,2449,2472,2500,2518,2536,2560,2586,2608,2633,2659,2686,2704,2722,2746,2771,2789,2816,2859,2882,2907,2931,2949,2975,2993,3016,3039,3063,3088,3106,3124,3142,3160,3178,3196,3214,3232,3250],{"intervention":39,"totalTrials":93,"cells":94},1,{"EARLY_PHASE1":95,"PHASE1":98,"PHASE2":100,"PHASE3":102,"PHASE4":104,"NA":117},{"trials":96,"activeCount":97},[],0,{"trials":99,"activeCount":97},[],{"trials":101,"activeCount":97},[],{"trials":103,"activeCount":97},[],{"trials":105,"activeCount":93,"soonestReadout":38},[106],{"nctId":36,"briefTitle":37,"status":107,"phases":108,"primaryCompletion":38,"completion":109,"start":110,"enrollment":111,"conditions":112,"interventions":115},"ACTIVE_NOT_RECRUITING",[89],"2029-12","2016-05",126,[113,114],"Pancreatic Fistula","Pancreatic Neoplasms",[39,116],"Pasireotide",{"trials":118,"activeCount":97},[],{"intervention":116,"totalTrials":93,"cells":120},{"EARLY_PHASE1":121,"PHASE1":123,"PHASE2":125,"PHASE3":127,"PHASE4":129,"NA":135},{"trials":122,"activeCount":97},[],{"trials":124,"activeCount":97},[],{"trials":126,"activeCount":97},[],{"trials":128,"activeCount":97},[],{"trials":130,"activeCount":93,"soonestReadout":38},[131],{"nctId":36,"briefTitle":37,"status":107,"phases":132,"primaryCompletion":38,"completion":109,"start":110,"enrollment":111,"conditions":133,"interventions":134},[89],[113,114],[39,116],{"trials":136,"activeCount":97},[],{"intervention":138,"totalTrials":93,"cells":139},"Placebos",{"EARLY_PHASE1":140,"PHASE1":142,"PHASE2":144,"PHASE3":146,"PHASE4":148,"NA":162},{"trials":141,"activeCount":97},[],{"trials":143,"activeCount":97},[],{"trials":145,"activeCount":97},[],{"trials":147,"activeCount":97},[],{"trials":149,"activeCount":93,"soonestReadout":43},[150],{"nctId":41,"briefTitle":42,"status":151,"phases":152,"primaryCompletion":43,"completion":153,"start":154,"enrollment":155,"conditions":156,"interventions":161},"NOT_YET_RECRUITING",[89],"2026-11","2019-11",202,[157,158,26,159,160],"Gastric Cancer","Anemia","Iron Deficiency Anemia","Surgery--Complications",[44,138],{"trials":163,"activeCount":97},[],{"intervention":73,"totalTrials":93,"cells":165},{"EARLY_PHASE1":166,"PHASE1":168,"PHASE2":170,"PHASE3":172,"PHASE4":174,"NA":188},{"trials":167,"activeCount":97},[],{"trials":169,"activeCount":97},[],{"trials":171,"activeCount":97},[],{"trials":173,"activeCount":97},[],{"trials":175,"activeCount":93,"soonestReadout":72},[176],{"nctId":70,"briefTitle":71,"status":177,"phases":178,"primaryCompletion":72,"completion":179,"start":180,"enrollment":181,"conditions":182,"interventions":187},"RECRUITING",[89],"2026-09","2022-08-17",800,[183,184,26,185,186],"Pancreas Cancer","Pancreas Neoplasm","Thrombosis","Bleeding",[73],{"trials":189,"activeCount":97},[],{"intervention":191,"totalTrials":93,"cells":192},"enoxaparin or tinzaparin or dalteparin",{"EARLY_PHASE1":193,"PHASE1":195,"PHASE2":197,"PHASE3":199,"PHASE4":201,"NA":217},{"trials":194,"activeCount":97},[],{"trials":196,"activeCount":97},[],{"trials":198,"activeCount":97},[],{"trials":200,"activeCount":97},[],{"trials":202,"activeCount":93,"soonestReadout":207},[203],{"nctId":204,"briefTitle":205,"status":177,"phases":206,"primaryCompletion":207,"completion":208,"start":209,"enrollment":210,"conditions":211,"interventions":215},"NCT04731558","Pre- Vs Postoperative Thromboprophylaxis for Liver Resection",[89],"2027-02","2027-03","2021-02-10",1012,[212,26,213,214,186],"Liver Cancer","Thrombosis, Deep Vein","Embolism, Pulmonary",[191,216],"No intervention",{"trials":218,"activeCount":97},[],{"intervention":216,"totalTrials":93,"cells":220},{"EARLY_PHASE1":221,"PHASE1":223,"PHASE2":225,"PHASE3":227,"PHASE4":229,"NA":235},{"trials":222,"activeCount":97},[],{"trials":224,"activeCount":97},[],{"trials":226,"activeCount":97},[],{"trials":228,"activeCount":97},[],{"trials":230,"activeCount":93,"soonestReadout":207},[231],{"nctId":204,"briefTitle":205,"status":177,"phases":232,"primaryCompletion":207,"completion":208,"start":209,"enrollment":210,"conditions":233,"interventions":234},[89],[212,26,213,214,186],[191,216],{"trials":236,"activeCount":97},[],{"intervention":49,"totalTrials":93,"cells":238},{"EARLY_PHASE1":239,"PHASE1":241,"PHASE2":243,"PHASE3":245,"PHASE4":247,"NA":264},{"trials":240,"activeCount":97},[],{"trials":242,"activeCount":97},[],{"trials":244,"activeCount":97},[],{"trials":246,"activeCount":97},[],{"trials":248,"activeCount":93,"soonestReadout":48},[249],{"nctId":46,"briefTitle":47,"status":107,"phases":250,"primaryCompletion":48,"completion":251,"start":252,"enrollment":253,"conditions":254,"interventions":262},[89],"2027-10-10","2020-03-18",604,[255,256,257,258,259,260,261,160],"Rectal Adenocarcinoma","Rectum Neoplasm","Rectum Carcinoma","Colorectal Cancer","Colorectal Neoplasms","Colorectal Carcinoma","Surgical Site Infection",[49,263],"Mechanical Bowel Preparation",{"trials":265,"activeCount":97},[],{"intervention":263,"totalTrials":93,"cells":267},{"EARLY_PHASE1":268,"PHASE1":270,"PHASE2":272,"PHASE3":274,"PHASE4":276,"NA":282},{"trials":269,"activeCount":97},[],{"trials":271,"activeCount":97},[],{"trials":273,"activeCount":97},[],{"trials":275,"activeCount":97},[],{"trials":277,"activeCount":93,"soonestReadout":48},[278],{"nctId":46,"briefTitle":47,"status":107,"phases":279,"primaryCompletion":48,"completion":251,"start":252,"enrollment":253,"conditions":280,"interventions":281},[89],[255,256,257,258,259,260,261,160],[49,263],{"trials":283,"activeCount":97},[],{"intervention":44,"totalTrials":285,"cells":286},2,{"EARLY_PHASE1":287,"PHASE1":289,"PHASE2":291,"PHASE3":293,"PHASE4":295,"NA":301},{"trials":288,"activeCount":97},[],{"trials":290,"activeCount":97},[],{"trials":292,"activeCount":97},[],{"trials":294,"activeCount":97},[],{"trials":296,"activeCount":93,"soonestReadout":43},[297],{"nctId":41,"briefTitle":42,"status":151,"phases":298,"primaryCompletion":43,"completion":153,"start":154,"enrollment":155,"conditions":299,"interventions":300},[89],[157,158,26,159,160],[44,138],{"trials":302,"activeCount":97},[303],{"nctId":304,"briefTitle":305,"status":306,"phases":307,"primaryCompletion":308,"completion":309,"start":310,"enrollment":311,"conditions":312,"interventions":314},"NCT04653181","Preoperative i.v. Iron Substitution in Patients With Colon Cancer","UNKNOWN",[90],"2024-12-31","2025-12-31","2020-10-01",514,[313],"Colon Cancer",[44],{"intervention":316,"totalTrials":93,"cells":317},"Metformin 1500 mg daily",{"EARLY_PHASE1":318,"PHASE1":320,"PHASE2":322,"PHASE3":324,"PHASE4":338,"NA":340},{"trials":319,"activeCount":97},[],{"trials":321,"activeCount":97},[],{"trials":323,"activeCount":97},[],{"trials":325,"activeCount":93,"soonestReadout":330},[326],{"nctId":327,"briefTitle":328,"status":151,"phases":329,"primaryCompletion":330,"completion":331,"start":332,"enrollment":333,"conditions":334,"interventions":336},"NCT07120815","Optimizing Metformin Use in Polycystic Ovary Syndrome",[88],"2027-12-31","2028-12-31","2025-09-01",184,[335],"Polycystic Ovary Syndrome (PCOS)",[316,337],"Metformin 2250 mg daily",{"trials":339,"activeCount":97},[],{"trials":341,"activeCount":97},[],{"intervention":337,"totalTrials":93,"cells":343},{"EARLY_PHASE1":344,"PHASE1":346,"PHASE2":348,"PHASE3":350,"PHASE4":356,"NA":358},{"trials":345,"activeCount":97},[],{"trials":347,"activeCount":97},[],{"trials":349,"activeCount":97},[],{"trials":351,"activeCount":93,"soonestReadout":330},[352],{"nctId":327,"briefTitle":328,"status":151,"phases":353,"primaryCompletion":330,"completion":331,"start":332,"enrollment":333,"conditions":354,"interventions":355},[88],[335],[316,337],{"trials":357,"activeCount":97},[],{"trials":359,"activeCount":97},[],{"intervention":361,"totalTrials":93,"cells":362},"mFOLFIRINOX neoadjuvant chemotherapy \u002F Nab-paclitaxel and gemcitabine",{"EARLY_PHASE1":363,"PHASE1":365,"PHASE2":367,"PHASE3":369,"PHASE4":380,"NA":382},{"trials":364,"activeCount":97},[],{"trials":366,"activeCount":97},[],{"trials":368,"activeCount":97},[],{"trials":370,"activeCount":93,"soonestReadout":375},[371],{"nctId":372,"briefTitle":373,"status":151,"phases":374,"primaryCompletion":375,"completion":375,"start":332,"enrollment":376,"conditions":377,"interventions":379},"NCT07155629","Neoadjuvant Treatment vs Upfront Surgery for Left-Sided Pancreatic Cancer",[88],"2030-08-31",381,[378],"Pancreatic Cancer Resectable",[361],{"trials":381,"activeCount":97},[],{"trials":383,"activeCount":97},[],{"intervention":385,"totalTrials":93,"cells":386},"Feacal microbial transplantation",{"EARLY_PHASE1":387,"PHASE1":389,"PHASE2":391,"PHASE3":393,"PHASE4":405,"NA":407},{"trials":388,"activeCount":97},[],{"trials":390,"activeCount":97},[],{"trials":392,"activeCount":97},[],{"trials":394,"activeCount":93,"soonestReadout":331},[395],{"nctId":396,"briefTitle":397,"status":177,"phases":398,"primaryCompletion":331,"completion":399,"start":400,"enrollment":401,"conditions":402,"interventions":404},"NCT06050148","Faecal Microbiota Transplantation as Means of Preventing Recurrent Urinary Tract Infections",[87,88],"2029-12-31","2023-08-01",100,[403],"Recurrent Urinary Tract Infection",[385],{"trials":406,"activeCount":97},[],{"trials":408,"activeCount":97},[],{"intervention":59,"totalTrials":93,"cells":410},{"EARLY_PHASE1":411,"PHASE1":413,"PHASE2":415,"PHASE3":417,"PHASE4":427,"NA":429},{"trials":412,"activeCount":97},[],{"trials":414,"activeCount":97},[],{"trials":416,"activeCount":97},[],{"trials":418,"activeCount":93,"soonestReadout":58},[419],{"nctId":56,"briefTitle":57,"status":107,"phases":420,"primaryCompletion":58,"completion":58,"start":421,"enrollment":422,"conditions":423,"interventions":425},[88],"2015-12",516,[424],"Breast Cancer",[59,426],"Trastuzumab",{"trials":428,"activeCount":97},[],{"trials":430,"activeCount":97},[],{"intervention":426,"totalTrials":93,"cells":432},{"EARLY_PHASE1":433,"PHASE1":435,"PHASE2":437,"PHASE3":439,"PHASE4":445,"NA":447},{"trials":434,"activeCount":97},[],{"trials":436,"activeCount":97},[],{"trials":438,"activeCount":97},[],{"trials":440,"activeCount":93,"soonestReadout":58},[441],{"nctId":56,"briefTitle":57,"status":107,"phases":442,"primaryCompletion":58,"completion":58,"start":421,"enrollment":422,"conditions":443,"interventions":444},[88],[424],[59,426],{"trials":446,"activeCount":97},[],{"trials":448,"activeCount":97},[],{"intervention":450,"totalTrials":93,"cells":451},"Healthy donor stool",{"EARLY_PHASE1":452,"PHASE1":454,"PHASE2":456,"PHASE3":458,"PHASE4":470,"NA":472},{"trials":453,"activeCount":97},[],{"trials":455,"activeCount":97},[],{"trials":457,"activeCount":97},[],{"trials":459,"activeCount":93,"soonestReadout":399},[460],{"nctId":461,"briefTitle":462,"status":177,"phases":463,"primaryCompletion":399,"completion":464,"start":465,"enrollment":466,"conditions":467,"interventions":469},"NCT07458984","FMT Capsules for rCDI",[88],"2030-12-31","2026-04-25",76,[468,54],"Clostridioides Difficile Infection Recurrence",[450],{"trials":471,"activeCount":97},[],{"trials":473,"activeCount":97},[],{"intervention":78,"totalTrials":93,"cells":475},{"EARLY_PHASE1":476,"PHASE1":478,"PHASE2":480,"PHASE3":505,"PHASE4":507,"NA":509},{"trials":477,"activeCount":97},[],{"trials":479,"activeCount":97},[],{"trials":481,"activeCount":93,"soonestReadout":77},[482],{"nctId":75,"briefTitle":76,"status":177,"phases":483,"primaryCompletion":77,"completion":77,"start":484,"enrollment":485,"conditions":486,"interventions":490},[87],"2021-12-10",250,[487,488,489],"Advanced Cancer","Solid Tumor","Haematological Malignancy",[78,491,492,493,494,495,496,497,498,499,500,501,502,503,504],"Cobimetinib","Vismodegib","Trastuzumab+Pertuzumab","Entrectinib","Atezolizumab","Vemurafenib","Regorafenib","Apalutamide","Abemaciclib","Tepotinib","Dabrafenib","Trametinib","Dabrafenib+Trametinib","Pemigatinib",{"trials":506,"activeCount":97},[],{"trials":508,"activeCount":97},[],{"trials":510,"activeCount":97},[],{"intervention":491,"totalTrials":93,"cells":512},{"EARLY_PHASE1":513,"PHASE1":515,"PHASE2":517,"PHASE3":523,"PHASE4":525,"NA":527},{"trials":514,"activeCount":97},[],{"trials":516,"activeCount":97},[],{"trials":518,"activeCount":93,"soonestReadout":77},[519],{"nctId":75,"briefTitle":76,"status":177,"phases":520,"primaryCompletion":77,"completion":77,"start":484,"enrollment":485,"conditions":521,"interventions":522},[87],[487,488,489],[78,491,492,493,494,495,496,497,498,499,500,501,502,503,504],{"trials":524,"activeCount":97},[],{"trials":526,"activeCount":97},[],{"trials":528,"activeCount":97},[],{"intervention":492,"totalTrials":93,"cells":530},{"EARLY_PHASE1":531,"PHASE1":533,"PHASE2":535,"PHASE3":541,"PHASE4":543,"NA":545},{"trials":532,"activeCount":97},[],{"trials":534,"activeCount":97},[],{"trials":536,"activeCount":93,"soonestReadout":77},[537],{"nctId":75,"briefTitle":76,"status":177,"phases":538,"primaryCompletion":77,"completion":77,"start":484,"enrollment":485,"conditions":539,"interventions":540},[87],[487,488,489],[78,491,492,493,494,495,496,497,498,499,500,501,502,503,504],{"trials":542,"activeCount":97},[],{"trials":544,"activeCount":97},[],{"trials":546,"activeCount":97},[],{"intervention":493,"totalTrials":93,"cells":548},{"EARLY_PHASE1":549,"PHASE1":551,"PHASE2":553,"PHASE3":559,"PHASE4":561,"NA":563},{"trials":550,"activeCount":97},[],{"trials":552,"activeCount":97},[],{"trials":554,"activeCount":93,"soonestReadout":77},[555],{"nctId":75,"briefTitle":76,"status":177,"phases":556,"primaryCompletion":77,"completion":77,"start":484,"enrollment":485,"conditions":557,"interventions":558},[87],[487,488,489],[78,491,492,493,494,495,496,497,498,499,500,501,502,503,504],{"trials":560,"activeCount":97},[],{"trials":562,"activeCount":97},[],{"trials":564,"activeCount":97},[],{"intervention":494,"totalTrials":93,"cells":566},{"EARLY_PHASE1":567,"PHASE1":569,"PHASE2":571,"PHASE3":577,"PHASE4":579,"NA":581},{"trials":568,"activeCount":97},[],{"trials":570,"activeCount":97},[],{"trials":572,"activeCount":93,"soonestReadout":77},[573],{"nctId":75,"briefTitle":76,"status":177,"phases":574,"primaryCompletion":77,"completion":77,"start":484,"enrollment":485,"conditions":575,"interventions":576},[87],[487,488,489],[78,491,492,493,494,495,496,497,498,499,500,501,502,503,504],{"trials":578,"activeCount":97},[],{"trials":580,"activeCount":97},[],{"trials":582,"activeCount":97},[],{"intervention":495,"totalTrials":93,"cells":584},{"EARLY_PHASE1":585,"PHASE1":587,"PHASE2":589,"PHASE3":595,"PHASE4":597,"NA":599},{"trials":586,"activeCount":97},[],{"trials":588,"activeCount":97},[],{"trials":590,"activeCount":93,"soonestReadout":77},[591],{"nctId":75,"briefTitle":76,"status":177,"phases":592,"primaryCompletion":77,"completion":77,"start":484,"enrollment":485,"conditions":593,"interventions":594},[87],[487,488,489],[78,491,492,493,494,495,496,497,498,499,500,501,502,503,504],{"trials":596,"activeCount":97},[],{"trials":598,"activeCount":97},[],{"trials":600,"activeCount":97},[],{"intervention":496,"totalTrials":93,"cells":602},{"EARLY_PHASE1":603,"PHASE1":605,"PHASE2":607,"PHASE3":613,"PHASE4":615,"NA":617},{"trials":604,"activeCount":97},[],{"trials":606,"activeCount":97},[],{"trials":608,"activeCount":93,"soonestReadout":77},[609],{"nctId":75,"briefTitle":76,"status":177,"phases":610,"primaryCompletion":77,"completion":77,"start":484,"enrollment":485,"conditions":611,"interventions":612},[87],[487,488,489],[78,491,492,493,494,495,496,497,498,499,500,501,502,503,504],{"trials":614,"activeCount":97},[],{"trials":616,"activeCount":97},[],{"trials":618,"activeCount":97},[],{"intervention":497,"totalTrials":93,"cells":620},{"EARLY_PHASE1":621,"PHASE1":623,"PHASE2":625,"PHASE3":631,"PHASE4":633,"NA":635},{"trials":622,"activeCount":97},[],{"trials":624,"activeCount":97},[],{"trials":626,"activeCount":93,"soonestReadout":77},[627],{"nctId":75,"briefTitle":76,"status":177,"phases":628,"primaryCompletion":77,"completion":77,"start":484,"enrollment":485,"conditions":629,"interventions":630},[87],[487,488,489],[78,491,492,493,494,495,496,497,498,499,500,501,502,503,504],{"trials":632,"activeCount":97},[],{"trials":634,"activeCount":97},[],{"trials":636,"activeCount":97},[],{"intervention":498,"totalTrials":93,"cells":638},{"EARLY_PHASE1":639,"PHASE1":641,"PHASE2":643,"PHASE3":649,"PHASE4":651,"NA":653},{"trials":640,"activeCount":97},[],{"trials":642,"activeCount":97},[],{"trials":644,"activeCount":93,"soonestReadout":77},[645],{"nctId":75,"briefTitle":76,"status":177,"phases":646,"primaryCompletion":77,"completion":77,"start":484,"enrollment":485,"conditions":647,"interventions":648},[87],[487,488,489],[78,491,492,493,494,495,496,497,498,499,500,501,502,503,504],{"trials":650,"activeCount":97},[],{"trials":652,"activeCount":97},[],{"trials":654,"activeCount":97},[],{"intervention":499,"totalTrials":93,"cells":656},{"EARLY_PHASE1":657,"PHASE1":659,"PHASE2":661,"PHASE3":667,"PHASE4":669,"NA":671},{"trials":658,"activeCount":97},[],{"trials":660,"activeCount":97},[],{"trials":662,"activeCount":93,"soonestReadout":77},[663],{"nctId":75,"briefTitle":76,"status":177,"phases":664,"primaryCompletion":77,"completion":77,"start":484,"enrollment":485,"conditions":665,"interventions":666},[87],[487,488,489],[78,491,492,493,494,495,496,497,498,499,500,501,502,503,504],{"trials":668,"activeCount":97},[],{"trials":670,"activeCount":97},[],{"trials":672,"activeCount":97},[],{"intervention":500,"totalTrials":93,"cells":674},{"EARLY_PHASE1":675,"PHASE1":677,"PHASE2":679,"PHASE3":685,"PHASE4":687,"NA":689},{"trials":676,"activeCount":97},[],{"trials":678,"activeCount":97},[],{"trials":680,"activeCount":93,"soonestReadout":77},[681],{"nctId":75,"briefTitle":76,"status":177,"phases":682,"primaryCompletion":77,"completion":77,"start":484,"enrollment":485,"conditions":683,"interventions":684},[87],[487,488,489],[78,491,492,493,494,495,496,497,498,499,500,501,502,503,504],{"trials":686,"activeCount":97},[],{"trials":688,"activeCount":97},[],{"trials":690,"activeCount":97},[],{"intervention":501,"totalTrials":93,"cells":692},{"EARLY_PHASE1":693,"PHASE1":695,"PHASE2":697,"PHASE3":703,"PHASE4":705,"NA":707},{"trials":694,"activeCount":97},[],{"trials":696,"activeCount":97},[],{"trials":698,"activeCount":93,"soonestReadout":77},[699],{"nctId":75,"briefTitle":76,"status":177,"phases":700,"primaryCompletion":77,"completion":77,"start":484,"enrollment":485,"conditions":701,"interventions":702},[87],[487,488,489],[78,491,492,493,494,495,496,497,498,499,500,501,502,503,504],{"trials":704,"activeCount":97},[],{"trials":706,"activeCount":97},[],{"trials":708,"activeCount":97},[],{"intervention":502,"totalTrials":93,"cells":710},{"EARLY_PHASE1":711,"PHASE1":713,"PHASE2":715,"PHASE3":721,"PHASE4":723,"NA":725},{"trials":712,"activeCount":97},[],{"trials":714,"activeCount":97},[],{"trials":716,"activeCount":93,"soonestReadout":77},[717],{"nctId":75,"briefTitle":76,"status":177,"phases":718,"primaryCompletion":77,"completion":77,"start":484,"enrollment":485,"conditions":719,"interventions":720},[87],[487,488,489],[78,491,492,493,494,495,496,497,498,499,500,501,502,503,504],{"trials":722,"activeCount":97},[],{"trials":724,"activeCount":97},[],{"trials":726,"activeCount":97},[],{"intervention":503,"totalTrials":93,"cells":728},{"EARLY_PHASE1":729,"PHASE1":731,"PHASE2":733,"PHASE3":739,"PHASE4":741,"NA":743},{"trials":730,"activeCount":97},[],{"trials":732,"activeCount":97},[],{"trials":734,"activeCount":93,"soonestReadout":77},[735],{"nctId":75,"briefTitle":76,"status":177,"phases":736,"primaryCompletion":77,"completion":77,"start":484,"enrollment":485,"conditions":737,"interventions":738},[87],[487,488,489],[78,491,492,493,494,495,496,497,498,499,500,501,502,503,504],{"trials":740,"activeCount":97},[],{"trials":742,"activeCount":97},[],{"trials":744,"activeCount":97},[],{"intervention":504,"totalTrials":93,"cells":746},{"EARLY_PHASE1":747,"PHASE1":749,"PHASE2":751,"PHASE3":757,"PHASE4":759,"NA":761},{"trials":748,"activeCount":97},[],{"trials":750,"activeCount":97},[],{"trials":752,"activeCount":93,"soonestReadout":77},[753],{"nctId":75,"briefTitle":76,"status":177,"phases":754,"primaryCompletion":77,"completion":77,"start":484,"enrollment":485,"conditions":755,"interventions":756},[87],[487,488,489],[78,491,492,493,494,495,496,497,498,499,500,501,502,503,504],{"trials":758,"activeCount":97},[],{"trials":760,"activeCount":97},[],{"trials":762,"activeCount":97},[],{"intervention":764,"totalTrials":93,"cells":765},"Daratumumab",{"EARLY_PHASE1":766,"PHASE1":768,"PHASE2":770,"PHASE3":784,"PHASE4":786,"NA":788},{"trials":767,"activeCount":97},[],{"trials":769,"activeCount":97},[],{"trials":771,"activeCount":93,"soonestReadout":776},[772],{"nctId":773,"briefTitle":774,"status":177,"phases":775,"primaryCompletion":776,"completion":776,"start":777,"enrollment":778,"conditions":779,"interventions":783},"NCT06889948","The Effect of Daratumumab in Patients with Monoclonal Gammopathy of Renal Significance (MGRS) in Finland",[87],"2027-06","2024-01-19",30,[780,781,782],"Kidney Failure","Paraproteinemias","Glomerulonephritis",[764],{"trials":785,"activeCount":97},[],{"trials":787,"activeCount":97},[],{"trials":789,"activeCount":97},[],{"intervention":83,"totalTrials":93,"cells":791},{"EARLY_PHASE1":792,"PHASE1":794,"PHASE2":805,"PHASE3":807,"PHASE4":809,"NA":811},{"trials":793,"activeCount":97},[],{"trials":795,"activeCount":93,"soonestReadout":82},[796],{"nctId":80,"briefTitle":81,"status":151,"phases":797,"primaryCompletion":82,"completion":82,"start":798,"enrollment":799,"conditions":800,"interventions":802},[86],"2026-03-04",12,[801],"Drug Drug Interaction",[83,803,804],"Cobisistat Tybost 150 mg","Cannabidiol Epidyolex 100 mg\u002Fml",{"trials":806,"activeCount":97},[],{"trials":808,"activeCount":97},[],{"trials":810,"activeCount":97},[],{"trials":812,"activeCount":97},[],{"intervention":803,"totalTrials":93,"cells":814},{"EARLY_PHASE1":815,"PHASE1":817,"PHASE2":823,"PHASE3":825,"PHASE4":827,"NA":829},{"trials":816,"activeCount":97},[],{"trials":818,"activeCount":93,"soonestReadout":82},[819],{"nctId":80,"briefTitle":81,"status":151,"phases":820,"primaryCompletion":82,"completion":82,"start":798,"enrollment":799,"conditions":821,"interventions":822},[86],[801],[83,803,804],{"trials":824,"activeCount":97},[],{"trials":826,"activeCount":97},[],{"trials":828,"activeCount":97},[],{"trials":830,"activeCount":97},[],{"intervention":804,"totalTrials":93,"cells":832},{"EARLY_PHASE1":833,"PHASE1":835,"PHASE2":841,"PHASE3":843,"PHASE4":845,"NA":847},{"trials":834,"activeCount":97},[],{"trials":836,"activeCount":93,"soonestReadout":82},[837],{"nctId":80,"briefTitle":81,"status":151,"phases":838,"primaryCompletion":82,"completion":82,"start":798,"enrollment":799,"conditions":839,"interventions":840},[86],[801],[83,803,804],{"trials":842,"activeCount":97},[],{"trials":844,"activeCount":97},[],{"trials":846,"activeCount":97},[],{"trials":848,"activeCount":97},[],{"intervention":850,"totalTrials":93,"cells":851},"Fluoropyrimidine",{"EARLY_PHASE1":852,"PHASE1":854,"PHASE2":856,"PHASE3":858,"PHASE4":860,"NA":862},{"trials":853,"activeCount":97},[],{"trials":855,"activeCount":97},[],{"trials":857,"activeCount":97},[],{"trials":859,"activeCount":97},[],{"trials":861,"activeCount":97},[],{"trials":863,"activeCount":93,"soonestReadout":869},[864],{"nctId":865,"briefTitle":866,"status":867,"phases":868,"primaryCompletion":869,"completion":869,"start":870,"enrollment":871,"conditions":872,"interventions":873},"NCT04260269","Feasibility of Switching Fluoropyrimidine Due to Cardiotoxicity Study","ENROLLING_BY_INVITATION",[],"2027-12","2018-06-01",200,[488],[850],{"intervention":64,"totalTrials":93,"cells":875},{"EARLY_PHASE1":876,"PHASE1":878,"PHASE2":880,"PHASE3":882,"PHASE4":884,"NA":886},{"trials":877,"activeCount":97},[],{"trials":879,"activeCount":97},[],{"trials":881,"activeCount":97},[],{"trials":883,"activeCount":97},[],{"trials":885,"activeCount":97},[],{"trials":887,"activeCount":93,"soonestReadout":63},[888],{"nctId":61,"briefTitle":62,"status":177,"phases":889,"primaryCompletion":63,"completion":890,"start":891,"enrollment":892,"conditions":893,"interventions":898},[90],"2030-12","2022-09-05",2278,[894,895,896,897],"Infection Post Op","Hysterectomy","Antibiotics","Prophylactic",[64],{"intervention":68,"totalTrials":93,"cells":900},{"EARLY_PHASE1":901,"PHASE1":903,"PHASE2":905,"PHASE3":907,"PHASE4":909,"NA":911},{"trials":902,"activeCount":97},[],{"trials":904,"activeCount":97},[],{"trials":906,"activeCount":97},[],{"trials":908,"activeCount":97},[],{"trials":910,"activeCount":97},[],{"trials":912,"activeCount":93,"soonestReadout":63},[913],{"nctId":66,"briefTitle":67,"status":177,"phases":914,"primaryCompletion":63,"completion":915,"start":916,"enrollment":917,"conditions":918,"interventions":922},[90],"2026-12","2022-11-22",40,[919,920,921],"Neuropathic Pain","Insomnia","Sleep Disorder",[68],{"intervention":924,"totalTrials":93,"cells":925},"Total neoadjuvant therapy",{"EARLY_PHASE1":926,"PHASE1":928,"PHASE2":930,"PHASE3":932,"PHASE4":934,"NA":936},{"trials":927,"activeCount":97},[],{"trials":929,"activeCount":97},[],{"trials":931,"activeCount":97},[],{"trials":933,"activeCount":97},[],{"trials":935,"activeCount":97},[],{"trials":937,"activeCount":93,"soonestReadout":942},[938],{"nctId":939,"briefTitle":940,"status":177,"phases":941,"primaryCompletion":942,"completion":943,"start":944,"enrollment":945,"conditions":946,"interventions":947},"NCT04842006","Systemic Neoadjuvant and Adjuvant Control by Precision Medicine in Rectal Cancer",[90],"2028-08-31","2031-12-31","2021-12-20",93,[258],[924],{"intervention":54,"totalTrials":93,"cells":949},{"EARLY_PHASE1":950,"PHASE1":952,"PHASE2":954,"PHASE3":956,"PHASE4":958,"NA":960},{"trials":951,"activeCount":97},[],{"trials":953,"activeCount":97},[],{"trials":955,"activeCount":97},[],{"trials":957,"activeCount":97},[],{"trials":959,"activeCount":97},[],{"trials":961,"activeCount":93,"soonestReadout":53},[962],{"nctId":51,"briefTitle":52,"status":177,"phases":963,"primaryCompletion":53,"completion":964,"start":965,"enrollment":966,"conditions":967,"interventions":970},[90],"2026-07-31","2022-04-30",45,[968,969],"Irritable Bowel Syndrome","Fecal Microbiota Transplantation",[54],{"intervention":972,"totalTrials":93,"cells":973},"Multiple daily injections of insulin",{"EARLY_PHASE1":974,"PHASE1":976,"PHASE2":978,"PHASE3":980,"PHASE4":982,"NA":984},{"trials":975,"activeCount":97},[],{"trials":977,"activeCount":97},[],{"trials":979,"activeCount":97},[],{"trials":981,"activeCount":97},[],{"trials":983,"activeCount":97},[],{"trials":985,"activeCount":93,"soonestReadout":990},[986],{"nctId":987,"briefTitle":988,"status":151,"phases":989,"primaryCompletion":990,"completion":331,"start":991,"enrollment":401,"conditions":992,"interventions":994},"NCT07423637","The Impact of Early Automated Insulin Delivery (AID) Therapy on Diabetes Control and Comorbidities, and Cost-effectiveness of AID Treatment",[90],"2027-09-30","2026-04-01",[993],"Type 1 Diabetes",[972],{"intervention":996,"totalTrials":285,"cells":997},"Prevenar13",{"EARLY_PHASE1":998,"PHASE1":1000,"PHASE2":1002,"PHASE3":1004,"PHASE4":1006,"NA":1034},{"trials":999,"activeCount":97},[],{"trials":1001,"activeCount":97},[],{"trials":1003,"activeCount":97},[],{"trials":1005,"activeCount":97},[],{"trials":1007,"activeCount":97},[1008,1022],{"nctId":1009,"briefTitle":1010,"status":1011,"phases":1012,"primaryCompletion":1013,"completion":1014,"start":1015,"enrollment":1016,"conditions":1017,"interventions":1020},"NCT01926860","PCV13 + Hepatitis A Vaccine for Adults","COMPLETED",[89],"2019-10-28","2020-04-28","2013-08-24",305,[1018,1019],"Measurement of Immune Response to Prevenar13","Measurement of Immune Response to Hepatitis A",[996,1021],"Hepatitis A vaccine",{"nctId":1023,"briefTitle":1024,"status":1011,"phases":1025,"primaryCompletion":1026,"completion":1026,"start":1027,"enrollment":1028,"conditions":1029,"interventions":1032},"NCT01781871","Immunogenicity of 13-valent Pneumococcal Conjugate Vaccine Compared to the Pneumococcal Polysaccharide Vaccine in Adult Kidney and Liver Transplant Patients",[89],"2017-10-04","2013-01",182,[1030,1031],"Kidney Transplantation","Liver Transplantation",[996,1033],"Pneumovax",{"trials":1035,"activeCount":97},[],{"intervention":1037,"totalTrials":93,"cells":1038},"Mepolizumab",{"EARLY_PHASE1":1039,"PHASE1":1041,"PHASE2":1043,"PHASE3":1045,"PHASE4":1047,"NA":1060},{"trials":1040,"activeCount":97},[],{"trials":1042,"activeCount":97},[],{"trials":1044,"activeCount":97},[],{"trials":1046,"activeCount":97},[],{"trials":1048,"activeCount":97},[1049],{"nctId":1050,"briefTitle":1051,"status":1011,"phases":1052,"primaryCompletion":1053,"completion":1053,"start":1054,"enrollment":1055,"conditions":1056,"interventions":1059},"NCT04823585","Aggravated Airway Inflammation: Research on Biological Treatment (Mepolizumab)",[89],"2025-01-16","2021-08-12",95,[1057,1058],"Asthma, Aspirin-Induced","Chronic Rhinosinusitis With Nasal Polyps",[1037],{"trials":1061,"activeCount":97},[],{"intervention":1063,"totalTrials":93,"cells":1064},"Albumin solution",{"EARLY_PHASE1":1065,"PHASE1":1067,"PHASE2":1069,"PHASE3":1071,"PHASE4":1073,"NA":1087},{"trials":1066,"activeCount":97},[],{"trials":1068,"activeCount":97},[],{"trials":1070,"activeCount":97},[],{"trials":1072,"activeCount":97},[],{"trials":1074,"activeCount":97},[1075],{"nctId":1076,"briefTitle":1077,"status":1011,"phases":1078,"primaryCompletion":1079,"completion":1080,"start":1081,"enrollment":1082,"conditions":1083,"interventions":1085},"NCT02560519","Albumin in Cardiac Surgery",[89],"2020-04-13","2020-11-04","2017-03-21",1386,[1084],"C.Surgical Procedure; Cardiac",[1063,1086],"Ringers acetate solution",{"trials":1088,"activeCount":97},[],{"intervention":1086,"totalTrials":93,"cells":1090},{"EARLY_PHASE1":1091,"PHASE1":1093,"PHASE2":1095,"PHASE3":1097,"PHASE4":1099,"NA":1105},{"trials":1092,"activeCount":97},[],{"trials":1094,"activeCount":97},[],{"trials":1096,"activeCount":97},[],{"trials":1098,"activeCount":97},[],{"trials":1100,"activeCount":97},[1101],{"nctId":1076,"briefTitle":1077,"status":1011,"phases":1102,"primaryCompletion":1079,"completion":1080,"start":1081,"enrollment":1082,"conditions":1103,"interventions":1104},[89],[1084],[1063,1086],{"trials":1106,"activeCount":97},[],{"intervention":1108,"totalTrials":93,"cells":1109},"Varilrix",{"EARLY_PHASE1":1110,"PHASE1":1112,"PHASE2":1114,"PHASE3":1116,"PHASE4":1118,"NA":1130},{"trials":1111,"activeCount":97},[],{"trials":1113,"activeCount":97},[],{"trials":1115,"activeCount":97},[],{"trials":1117,"activeCount":97},[],{"trials":1119,"activeCount":97},[1120],{"nctId":1121,"briefTitle":1122,"status":306,"phases":1123,"primaryCompletion":1124,"completion":1125,"start":1126,"enrollment":24,"conditions":1127,"interventions":1129},"NCT02383797","Immunodeficiency in Cartilage-hair Hypoplasia: Sub-project on Safety of Vaccination Against Chickenpox",[89],"2019-10","2020-02","2015-02",[1128],"Cartilage-hair Hypoplasia",[1108],{"trials":1131,"activeCount":97},[],{"intervention":1133,"totalTrials":93,"cells":1134},"Amorolfine",{"EARLY_PHASE1":1135,"PHASE1":1137,"PHASE2":1139,"PHASE3":1141,"PHASE4":1143,"NA":1156},{"trials":1136,"activeCount":97},[],{"trials":1138,"activeCount":97},[],{"trials":1140,"activeCount":97},[],{"trials":1142,"activeCount":97},[],{"trials":1144,"activeCount":97},[1145],{"nctId":1146,"briefTitle":1147,"status":1011,"phases":1148,"primaryCompletion":1149,"completion":1149,"start":1150,"enrollment":1151,"conditions":1152,"interventions":1154},"NCT01851590","Resin vs. Amorolfine vs. Terbinafine Treatment in Onychomycosis",[89],"2014-10","2013-10",129,[1153],"Onychomycosis",[1133,1155],"Terbinafine",{"trials":1157,"activeCount":97},[],{"intervention":1155,"totalTrials":93,"cells":1159},{"EARLY_PHASE1":1160,"PHASE1":1162,"PHASE2":1164,"PHASE3":1166,"PHASE4":1168,"NA":1174},{"trials":1161,"activeCount":97},[],{"trials":1163,"activeCount":97},[],{"trials":1165,"activeCount":97},[],{"trials":1167,"activeCount":97},[],{"trials":1169,"activeCount":97},[1170],{"nctId":1146,"briefTitle":1147,"status":1011,"phases":1171,"primaryCompletion":1149,"completion":1149,"start":1150,"enrollment":1151,"conditions":1172,"interventions":1173},[89],[1153],[1133,1155],{"trials":1175,"activeCount":97},[],{"intervention":1177,"totalTrials":93,"cells":1178},"Teriparatide",{"EARLY_PHASE1":1179,"PHASE1":1181,"PHASE2":1183,"PHASE3":1185,"PHASE4":1187,"NA":1198},{"trials":1180,"activeCount":97},[],{"trials":1182,"activeCount":97},[],{"trials":1184,"activeCount":97},[],{"trials":1186,"activeCount":97},[],{"trials":1188,"activeCount":97},[1189],{"nctId":1190,"briefTitle":1191,"status":1011,"phases":1192,"primaryCompletion":1193,"completion":1193,"start":1194,"enrollment":21,"conditions":1195,"interventions":1197},"NCT01360424","Teriparatide Treatment in Patients With Inherited Osteoporosis",[89],"2013-11","2011-05",[1196],"Osteoporosis",[1177],{"trials":1199,"activeCount":97},[],{"intervention":1201,"totalTrials":93,"cells":1202},"Raltegravir",{"EARLY_PHASE1":1203,"PHASE1":1205,"PHASE2":1207,"PHASE3":1209,"PHASE4":1211,"NA":1225},{"trials":1204,"activeCount":97},[],{"trials":1206,"activeCount":97},[],{"trials":1208,"activeCount":97},[],{"trials":1210,"activeCount":97},[],{"trials":1212,"activeCount":97},[1213],{"nctId":1214,"briefTitle":1215,"status":1011,"phases":1216,"primaryCompletion":1217,"completion":1218,"start":1219,"enrollment":966,"conditions":1220,"interventions":1224},"NCT03374358","Effect on Liver Fat and Metabolic Parameters When Switching a Protease Inhibitor or Efavirenz to Raltegravir",[89],"2019-11-02","2019-11-30","2018-01-10",[1221,1222,1223],"HIV Seropositivity","Metabolic Syndrome","Fatty Liver",[1201],{"trials":1226,"activeCount":97},[],{"intervention":1021,"totalTrials":93,"cells":1228},{"EARLY_PHASE1":1229,"PHASE1":1231,"PHASE2":1233,"PHASE3":1235,"PHASE4":1237,"NA":1243},{"trials":1230,"activeCount":97},[],{"trials":1232,"activeCount":97},[],{"trials":1234,"activeCount":97},[],{"trials":1236,"activeCount":97},[],{"trials":1238,"activeCount":97},[1239],{"nctId":1009,"briefTitle":1010,"status":1011,"phases":1240,"primaryCompletion":1013,"completion":1014,"start":1015,"enrollment":1016,"conditions":1241,"interventions":1242},[89],[1018,1019],[996,1021],{"trials":1244,"activeCount":97},[],{"intervention":1246,"totalTrials":93,"cells":1247},"fentanyl",{"EARLY_PHASE1":1248,"PHASE1":1250,"PHASE2":1252,"PHASE3":1254,"PHASE4":1256,"NA":1271},{"trials":1249,"activeCount":97},[],{"trials":1251,"activeCount":97},[],{"trials":1253,"activeCount":97},[],{"trials":1255,"activeCount":97},[],{"trials":1257,"activeCount":97},[1258],{"nctId":1259,"briefTitle":1260,"status":1011,"phases":1261,"primaryCompletion":1262,"completion":1262,"start":1263,"enrollment":1264,"conditions":1265,"interventions":1267},"NCT01079312","Patient-controlled Sedation With Propofol and Remifentanyl for Endoscopic Retrograde Cholangiopancreatography (ERCP)",[89],"2009-04","2009-01",80,[1266],"Endoscopic Retrograde Cholangiopancreatography",[1268,1246,1269,1270],"propofol","sedative mixture","remifentanil hydrochlorid",{"trials":1272,"activeCount":97},[],{"intervention":1269,"totalTrials":93,"cells":1274},{"EARLY_PHASE1":1275,"PHASE1":1277,"PHASE2":1279,"PHASE3":1281,"PHASE4":1283,"NA":1289},{"trials":1276,"activeCount":97},[],{"trials":1278,"activeCount":97},[],{"trials":1280,"activeCount":97},[],{"trials":1282,"activeCount":97},[],{"trials":1284,"activeCount":97},[1285],{"nctId":1259,"briefTitle":1260,"status":1011,"phases":1286,"primaryCompletion":1262,"completion":1262,"start":1263,"enrollment":1264,"conditions":1287,"interventions":1288},[89],[1266],[1268,1246,1269,1270],{"trials":1290,"activeCount":97},[],{"intervention":1270,"totalTrials":93,"cells":1292},{"EARLY_PHASE1":1293,"PHASE1":1295,"PHASE2":1297,"PHASE3":1299,"PHASE4":1301,"NA":1307},{"trials":1294,"activeCount":97},[],{"trials":1296,"activeCount":97},[],{"trials":1298,"activeCount":97},[],{"trials":1300,"activeCount":97},[],{"trials":1302,"activeCount":97},[1303],{"nctId":1259,"briefTitle":1260,"status":1011,"phases":1304,"primaryCompletion":1262,"completion":1262,"start":1263,"enrollment":1264,"conditions":1305,"interventions":1306},[89],[1266],[1268,1246,1269,1270],{"trials":1308,"activeCount":97},[],{"intervention":1310,"totalTrials":93,"cells":1311},"Anesthetics, Local",{"EARLY_PHASE1":1312,"PHASE1":1314,"PHASE2":1316,"PHASE3":1318,"PHASE4":1320,"NA":1336},{"trials":1313,"activeCount":97},[],{"trials":1315,"activeCount":97},[],{"trials":1317,"activeCount":97},[],{"trials":1319,"activeCount":97},[],{"trials":1321,"activeCount":97},[1322],{"nctId":1323,"briefTitle":1324,"status":306,"phases":1325,"primaryCompletion":1326,"completion":1327,"start":1149,"enrollment":1328,"conditions":1329,"interventions":1334},"NCT02105090","Efficacy Study of Articaine Lozenge to Enhance the Procedural Compliance of the Adults Undergoing Gastroduodenoscopy",[89],"2019-12","2020-09",120,[1330,1331,1332,1333],"Dyspepsia","Hematemesis","Abdominal Pain","Heartburn",[1310,1335],"Sodium Chloride 0.9%",{"trials":1337,"activeCount":97},[],{"intervention":1335,"totalTrials":93,"cells":1339},{"EARLY_PHASE1":1340,"PHASE1":1342,"PHASE2":1344,"PHASE3":1346,"PHASE4":1348,"NA":1354},{"trials":1341,"activeCount":97},[],{"trials":1343,"activeCount":97},[],{"trials":1345,"activeCount":97},[],{"trials":1347,"activeCount":97},[],{"trials":1349,"activeCount":97},[1350],{"nctId":1323,"briefTitle":1324,"status":306,"phases":1351,"primaryCompletion":1326,"completion":1327,"start":1149,"enrollment":1328,"conditions":1352,"interventions":1353},[89],[1330,1331,1332,1333],[1310,1335],{"trials":1355,"activeCount":97},[],{"intervention":1357,"totalTrials":93,"cells":1358},"Vivotif",{"EARLY_PHASE1":1359,"PHASE1":1361,"PHASE2":1363,"PHASE3":1365,"PHASE4":1367,"NA":1377},{"trials":1360,"activeCount":97},[],{"trials":1362,"activeCount":97},[],{"trials":1364,"activeCount":97},[],{"trials":1366,"activeCount":97},[],{"trials":1368,"activeCount":97},[1369],{"nctId":1370,"briefTitle":1371,"status":306,"phases":1372,"primaryCompletion":1326,"completion":1326,"start":1150,"enrollment":401,"conditions":1373,"interventions":1375},"NCT02121145","Cross-reactive Immunity Elicited by Oral and Parenteral Typhoid Vaccines",[89],[1374],"Healthy",[1357,1376],"Typherix",{"trials":1378,"activeCount":97},[],{"intervention":1376,"totalTrials":93,"cells":1380},{"EARLY_PHASE1":1381,"PHASE1":1383,"PHASE2":1385,"PHASE3":1387,"PHASE4":1389,"NA":1395},{"trials":1382,"activeCount":97},[],{"trials":1384,"activeCount":97},[],{"trials":1386,"activeCount":97},[],{"trials":1388,"activeCount":97},[],{"trials":1390,"activeCount":97},[1391],{"nctId":1370,"briefTitle":1371,"status":306,"phases":1392,"primaryCompletion":1326,"completion":1326,"start":1150,"enrollment":401,"conditions":1393,"interventions":1394},[89],[1374],[1357,1376],{"trials":1396,"activeCount":97},[],{"intervention":1398,"totalTrials":93,"cells":1399},"alfentanil",{"EARLY_PHASE1":1400,"PHASE1":1402,"PHASE2":1404,"PHASE3":1406,"PHASE4":1408,"NA":1422},{"trials":1401,"activeCount":97},[],{"trials":1403,"activeCount":97},[],{"trials":1405,"activeCount":97},[],{"trials":1407,"activeCount":97},[],{"trials":1409,"activeCount":97},[1410],{"nctId":1411,"briefTitle":1412,"status":1011,"phases":1413,"primaryCompletion":1414,"completion":1414,"start":1415,"enrollment":1416,"conditions":1417,"interventions":1420},"NCT01350037","Alfentanil Versus Remifentanil in Patient-controlled Sedation During Endoscopic Retrograde Cholangiopancreatography (ERCP)",[89],"2009-09","2009-06",81,[1418,1419],"Biliary Tract Diseases","Pancreatic Diseases",[1398,1421],"remifentanil",{"trials":1423,"activeCount":97},[],{"intervention":1421,"totalTrials":93,"cells":1425},{"EARLY_PHASE1":1426,"PHASE1":1428,"PHASE2":1430,"PHASE3":1432,"PHASE4":1434,"NA":1440},{"trials":1427,"activeCount":97},[],{"trials":1429,"activeCount":97},[],{"trials":1431,"activeCount":97},[],{"trials":1433,"activeCount":97},[],{"trials":1435,"activeCount":97},[1436],{"nctId":1411,"briefTitle":1412,"status":1011,"phases":1437,"primaryCompletion":1414,"completion":1414,"start":1415,"enrollment":1416,"conditions":1438,"interventions":1439},[89],[1418,1419],[1398,1421],{"trials":1441,"activeCount":97},[],{"intervention":1443,"totalTrials":93,"cells":1444},"Articaine hydrochloride 2% solution",{"EARLY_PHASE1":1445,"PHASE1":1447,"PHASE2":1449,"PHASE3":1451,"PHASE4":1453,"NA":1470},{"trials":1446,"activeCount":97},[],{"trials":1448,"activeCount":97},[],{"trials":1450,"activeCount":97},[],{"trials":1452,"activeCount":97},[],{"trials":1454,"activeCount":97},[1455],{"nctId":1456,"briefTitle":1457,"status":1458,"phases":1459,"primaryCompletion":1460,"completion":1460,"start":1461,"enrollment":1462,"conditions":1463,"interventions":1468},"NCT01536717","Comparison of the Local Anaesthetics Articaine and Bupivacaine in Treatment of Acute Sternum Pain After Heart Surgery","SUSPENDED",[89],"2022-12","2012-03",36,[1464,1465,1466,1467],"Diseases of Mitral Valve","Aortic Valve Disorder","Atrial Septal Defects","Intracardiac Myxoma",[1443,1469],"Sodium Chloride",{"trials":1471,"activeCount":97},[],{"intervention":1469,"totalTrials":93,"cells":1473},{"EARLY_PHASE1":1474,"PHASE1":1476,"PHASE2":1478,"PHASE3":1480,"PHASE4":1482,"NA":1488},{"trials":1475,"activeCount":97},[],{"trials":1477,"activeCount":97},[],{"trials":1479,"activeCount":97},[],{"trials":1481,"activeCount":97},[],{"trials":1483,"activeCount":97},[1484],{"nctId":1456,"briefTitle":1457,"status":1458,"phases":1485,"primaryCompletion":1460,"completion":1460,"start":1461,"enrollment":1462,"conditions":1486,"interventions":1487},[89],[1464,1465,1466,1467],[1443,1469],{"trials":1489,"activeCount":97},[],{"intervention":1491,"totalTrials":93,"cells":1492},"Metronidazole",{"EARLY_PHASE1":1493,"PHASE1":1495,"PHASE2":1497,"PHASE3":1499,"PHASE4":1501,"NA":1515},{"trials":1494,"activeCount":97},[],{"trials":1496,"activeCount":97},[],{"trials":1498,"activeCount":97},[],{"trials":1500,"activeCount":97},[],{"trials":1502,"activeCount":97},[1503],{"nctId":1504,"briefTitle":1505,"status":1506,"phases":1507,"primaryCompletion":1508,"completion":1508,"start":1509,"enrollment":1510,"conditions":1511,"interventions":1513},"NCT02942485","Treatment of Giardia Lamblia Infections in Children","TERMINATED",[89],"2019-12-31","2016-12-01",8,[1512],"GIARDIASIS",[1491,1514],"Tinidazole",{"trials":1516,"activeCount":97},[],{"intervention":1514,"totalTrials":93,"cells":1518},{"EARLY_PHASE1":1519,"PHASE1":1521,"PHASE2":1523,"PHASE3":1525,"PHASE4":1527,"NA":1533},{"trials":1520,"activeCount":97},[],{"trials":1522,"activeCount":97},[],{"trials":1524,"activeCount":97},[],{"trials":1526,"activeCount":97},[],{"trials":1528,"activeCount":97},[1529],{"nctId":1504,"briefTitle":1505,"status":1506,"phases":1530,"primaryCompletion":1508,"completion":1508,"start":1509,"enrollment":1510,"conditions":1531,"interventions":1532},[89],[1512],[1491,1514],{"trials":1534,"activeCount":97},[],{"intervention":1536,"totalTrials":93,"cells":1537},"Morphine, memantine",{"EARLY_PHASE1":1538,"PHASE1":1540,"PHASE2":1542,"PHASE3":1544,"PHASE4":1546,"NA":1559},{"trials":1539,"activeCount":97},[],{"trials":1541,"activeCount":97},[],{"trials":1543,"activeCount":97},[],{"trials":1545,"activeCount":97},[],{"trials":1547,"activeCount":97},[1548],{"nctId":1549,"briefTitle":1550,"status":1011,"phases":1551,"primaryCompletion":1552,"completion":1553,"start":1554,"enrollment":1555,"conditions":1556,"interventions":1558},"NCT02467556","Psychological Intervention and Physiotherapy With Medication Improves CRPS Patients Outcome",[89],"2014-05","2014-06","2011-03",10,[1557],"CRPS",[1536],{"trials":1560,"activeCount":97},[],{"intervention":1562,"totalTrials":93,"cells":1563},"Amlodipine",{"EARLY_PHASE1":1564,"PHASE1":1566,"PHASE2":1568,"PHASE3":1570,"PHASE4":1572,"NA":1588},{"trials":1565,"activeCount":97},[],{"trials":1567,"activeCount":97},[],{"trials":1569,"activeCount":97},[],{"trials":1571,"activeCount":97},[],{"trials":1573,"activeCount":97},[1574],{"nctId":1575,"briefTitle":1576,"status":1011,"phases":1577,"primaryCompletion":1578,"completion":1578,"start":1579,"enrollment":1580,"conditions":1581,"interventions":1584},"NCT03276598","A Study on Molecular Genetics of Drug Responsiveness in Essential Hypertension",[89],"2004-04-01","1999-11-25",233,[1582,1583],"Hypertension","Pharmacogenetics",[1562,1585,1586,1587],"Bisoprolol","Hydrochlorothiazide","Losartan",{"trials":1589,"activeCount":97},[],{"intervention":1585,"totalTrials":93,"cells":1591},{"EARLY_PHASE1":1592,"PHASE1":1594,"PHASE2":1596,"PHASE3":1598,"PHASE4":1600,"NA":1606},{"trials":1593,"activeCount":97},[],{"trials":1595,"activeCount":97},[],{"trials":1597,"activeCount":97},[],{"trials":1599,"activeCount":97},[],{"trials":1601,"activeCount":97},[1602],{"nctId":1575,"briefTitle":1576,"status":1011,"phases":1603,"primaryCompletion":1578,"completion":1578,"start":1579,"enrollment":1580,"conditions":1604,"interventions":1605},[89],[1582,1583],[1562,1585,1586,1587],{"trials":1607,"activeCount":97},[],{"intervention":1586,"totalTrials":93,"cells":1609},{"EARLY_PHASE1":1610,"PHASE1":1612,"PHASE2":1614,"PHASE3":1616,"PHASE4":1618,"NA":1624},{"trials":1611,"activeCount":97},[],{"trials":1613,"activeCount":97},[],{"trials":1615,"activeCount":97},[],{"trials":1617,"activeCount":97},[],{"trials":1619,"activeCount":97},[1620],{"nctId":1575,"briefTitle":1576,"status":1011,"phases":1621,"primaryCompletion":1578,"completion":1578,"start":1579,"enrollment":1580,"conditions":1622,"interventions":1623},[89],[1582,1583],[1562,1585,1586,1587],{"trials":1625,"activeCount":97},[],{"intervention":1587,"totalTrials":93,"cells":1627},{"EARLY_PHASE1":1628,"PHASE1":1630,"PHASE2":1632,"PHASE3":1634,"PHASE4":1636,"NA":1642},{"trials":1629,"activeCount":97},[],{"trials":1631,"activeCount":97},[],{"trials":1633,"activeCount":97},[],{"trials":1635,"activeCount":97},[],{"trials":1637,"activeCount":97},[1638],{"nctId":1575,"briefTitle":1576,"status":1011,"phases":1639,"primaryCompletion":1578,"completion":1578,"start":1579,"enrollment":1580,"conditions":1640,"interventions":1641},[89],[1582,1583],[1562,1585,1586,1587],{"trials":1643,"activeCount":97},[],{"intervention":1645,"totalTrials":93,"cells":1646},"articaine",{"EARLY_PHASE1":1647,"PHASE1":1649,"PHASE2":1651,"PHASE3":1653,"PHASE4":1655,"NA":1666},{"trials":1648,"activeCount":97},[],{"trials":1650,"activeCount":97},[],{"trials":1652,"activeCount":97},[],{"trials":1654,"activeCount":97},[],{"trials":1656,"activeCount":97},[1657],{"nctId":1658,"briefTitle":1659,"status":1011,"phases":1660,"primaryCompletion":1661,"completion":1661,"start":1414,"enrollment":1662,"conditions":1663,"interventions":1665},"NCT01350050","Topical Pharyngeal Anesthesia With Articaine for Gastroscopy",[89],"2009-12",18,[1664],"Gastroscopy",[1645],{"trials":1667,"activeCount":97},[],{"intervention":1669,"totalTrials":93,"cells":1670},"Precedex",{"EARLY_PHASE1":1671,"PHASE1":1673,"PHASE2":1675,"PHASE3":1677,"PHASE4":1679,"NA":1692},{"trials":1672,"activeCount":97},[],{"trials":1674,"activeCount":97},[],{"trials":1676,"activeCount":97},[],{"trials":1678,"activeCount":97},[],{"trials":1680,"activeCount":97},[1681],{"nctId":1682,"briefTitle":1683,"status":1011,"phases":1684,"primaryCompletion":1685,"completion":1685,"start":1686,"enrollment":1687,"conditions":1688,"interventions":1690},"NCT01070680","Dexmedetomidine Versus Placebo in Endoscopic Retrograde Cholangiopancreatography (ERCP) Sedation",[89],"2011-01","2010-03",50,[1689],"Pancreatitis",[1669,1691],"sodium chlorid 0,9%",{"trials":1693,"activeCount":97},[],{"intervention":1691,"totalTrials":93,"cells":1695},{"EARLY_PHASE1":1696,"PHASE1":1698,"PHASE2":1700,"PHASE3":1702,"PHASE4":1704,"NA":1710},{"trials":1697,"activeCount":97},[],{"trials":1699,"activeCount":97},[],{"trials":1701,"activeCount":97},[],{"trials":1703,"activeCount":97},[],{"trials":1705,"activeCount":97},[1706],{"nctId":1682,"briefTitle":1683,"status":1011,"phases":1707,"primaryCompletion":1685,"completion":1685,"start":1686,"enrollment":1687,"conditions":1708,"interventions":1709},[89],[1689],[1669,1691],{"trials":1711,"activeCount":97},[],{"intervention":1713,"totalTrials":93,"cells":1714},"Pneumococcal polysaccharide vaccine",{"EARLY_PHASE1":1715,"PHASE1":1717,"PHASE2":1719,"PHASE3":1721,"PHASE4":1723,"NA":1736},{"trials":1716,"activeCount":97},[],{"trials":1718,"activeCount":97},[],{"trials":1720,"activeCount":97},[],{"trials":1722,"activeCount":97},[],{"trials":1724,"activeCount":97},[1725],{"nctId":1726,"briefTitle":1727,"status":1011,"phases":1728,"primaryCompletion":1729,"completion":1729,"start":1730,"enrollment":1731,"conditions":1732,"interventions":1734},"NCT01402245","Targeting of Immune Response After Pneumococcal Vaccination",[89],"2010-06","2005-01",42,[1733],"Pneumococcal Pneumonia",[1713,1735],"pneumococcal conjugate vaccine",{"trials":1737,"activeCount":97},[],{"intervention":1735,"totalTrials":93,"cells":1739},{"EARLY_PHASE1":1740,"PHASE1":1742,"PHASE2":1744,"PHASE3":1746,"PHASE4":1748,"NA":1754},{"trials":1741,"activeCount":97},[],{"trials":1743,"activeCount":97},[],{"trials":1745,"activeCount":97},[],{"trials":1747,"activeCount":97},[],{"trials":1749,"activeCount":97},[1750],{"nctId":1726,"briefTitle":1727,"status":1011,"phases":1751,"primaryCompletion":1729,"completion":1729,"start":1730,"enrollment":1731,"conditions":1752,"interventions":1753},[89],[1733],[1713,1735],{"trials":1755,"activeCount":97},[],{"intervention":1757,"totalTrials":93,"cells":1758},"Oral typhoid fever vaccine",{"EARLY_PHASE1":1759,"PHASE1":1761,"PHASE2":1763,"PHASE3":1765,"PHASE4":1767,"NA":1782},{"trials":1760,"activeCount":97},[],{"trials":1762,"activeCount":97},[],{"trials":1764,"activeCount":97},[],{"trials":1766,"activeCount":97},[],{"trials":1768,"activeCount":97},[1769],{"nctId":1770,"briefTitle":1771,"status":1011,"phases":1772,"primaryCompletion":1773,"completion":1773,"start":1774,"enrollment":1775,"conditions":1776,"interventions":1780},"NCT06104345","Immune Response Elicited by Concomitant Administration of Oral Typhoid Fever (Vivotif®) and Cholera (Dukoral®) Vaccines",[89],"2024-06-26","2023-10-25",65,[1777,1778,1779],"Vaccine-Preventable Diseases","Typhoid Fever","Cholera",[1757,1781],"Oral cholera vaccine",{"trials":1783,"activeCount":97},[],{"intervention":1781,"totalTrials":93,"cells":1785},{"EARLY_PHASE1":1786,"PHASE1":1788,"PHASE2":1790,"PHASE3":1792,"PHASE4":1794,"NA":1800},{"trials":1787,"activeCount":97},[],{"trials":1789,"activeCount":97},[],{"trials":1791,"activeCount":97},[],{"trials":1793,"activeCount":97},[],{"trials":1795,"activeCount":97},[1796],{"nctId":1770,"briefTitle":1771,"status":1011,"phases":1797,"primaryCompletion":1773,"completion":1773,"start":1774,"enrollment":1775,"conditions":1798,"interventions":1799},[89],[1777,1778,1779],[1757,1781],{"trials":1801,"activeCount":97},[],{"intervention":1803,"totalTrials":93,"cells":1804},"Activated protein C",{"EARLY_PHASE1":1805,"PHASE1":1807,"PHASE2":1809,"PHASE3":1811,"PHASE4":1813,"NA":1825},{"trials":1806,"activeCount":97},[],{"trials":1808,"activeCount":97},[],{"trials":1810,"activeCount":97},[],{"trials":1812,"activeCount":97},[],{"trials":1814,"activeCount":97},[1815],{"nctId":1816,"briefTitle":1817,"status":1011,"phases":1818,"primaryCompletion":1819,"completion":1819,"start":1820,"enrollment":1821,"conditions":1822,"interventions":1824},"NCT01017107","Activated Protein C in Severe Acute Pancreatitis",[89],"2007-09","2003-06",32,[1823],"Acute Pancreatitis",[1803],{"trials":1826,"activeCount":97},[],{"intervention":1828,"totalTrials":93,"cells":1829},"Spinal analgesia for labour pain",{"EARLY_PHASE1":1830,"PHASE1":1832,"PHASE2":1834,"PHASE3":1836,"PHASE4":1838,"NA":1850},{"trials":1831,"activeCount":97},[],{"trials":1833,"activeCount":97},[],{"trials":1835,"activeCount":97},[],{"trials":1837,"activeCount":97},[],{"trials":1839,"activeCount":97},[1840],{"nctId":1841,"briefTitle":1842,"status":1011,"phases":1843,"primaryCompletion":1844,"completion":1844,"start":1845,"enrollment":1264,"conditions":1846,"interventions":1848},"NCT02885350","Spinal or Epidural Fentanyl or Sufentanil for Labour Pain in Early Phase of the Labour",[89],"2018-05","2016-09",[1847],"Labor Pain",[1828,1849],"Epidural analgesia for labour pain",{"trials":1851,"activeCount":97},[],{"intervention":1849,"totalTrials":93,"cells":1853},{"EARLY_PHASE1":1854,"PHASE1":1856,"PHASE2":1858,"PHASE3":1860,"PHASE4":1862,"NA":1868},{"trials":1855,"activeCount":97},[],{"trials":1857,"activeCount":97},[],{"trials":1859,"activeCount":97},[],{"trials":1861,"activeCount":97},[],{"trials":1863,"activeCount":97},[1864],{"nctId":1841,"briefTitle":1842,"status":1011,"phases":1865,"primaryCompletion":1844,"completion":1844,"start":1845,"enrollment":1264,"conditions":1866,"interventions":1867},[89],[1847],[1828,1849],{"trials":1869,"activeCount":97},[],{"intervention":1871,"totalTrials":93,"cells":1872},"Ethinyl estradiol \u002F dienogest",{"EARLY_PHASE1":1873,"PHASE1":1875,"PHASE2":1877,"PHASE3":1879,"PHASE4":1881,"NA":1895},{"trials":1874,"activeCount":97},[],{"trials":1876,"activeCount":97},[],{"trials":1878,"activeCount":97},[],{"trials":1880,"activeCount":97},[],{"trials":1882,"activeCount":97},[1883],{"nctId":1884,"briefTitle":1885,"status":1011,"phases":1886,"primaryCompletion":1887,"completion":1887,"start":1888,"enrollment":1889,"conditions":1890,"interventions":1892},"NCT02352090","Synthetic vs Natural Estrogen in Combined Oral Contraception",[89],"2018-12-30","2015-04-01",59,[1891],"Contraception",[1871,1893,1894],"Estradiol valerate \u002F dienogest","Dienogest",{"trials":1896,"activeCount":97},[],{"intervention":1893,"totalTrials":93,"cells":1898},{"EARLY_PHASE1":1899,"PHASE1":1901,"PHASE2":1903,"PHASE3":1905,"PHASE4":1907,"NA":1913},{"trials":1900,"activeCount":97},[],{"trials":1902,"activeCount":97},[],{"trials":1904,"activeCount":97},[],{"trials":1906,"activeCount":97},[],{"trials":1908,"activeCount":97},[1909],{"nctId":1884,"briefTitle":1885,"status":1011,"phases":1910,"primaryCompletion":1887,"completion":1887,"start":1888,"enrollment":1889,"conditions":1911,"interventions":1912},[89],[1891],[1871,1893,1894],{"trials":1914,"activeCount":97},[],{"intervention":1894,"totalTrials":93,"cells":1916},{"EARLY_PHASE1":1917,"PHASE1":1919,"PHASE2":1921,"PHASE3":1923,"PHASE4":1925,"NA":1931},{"trials":1918,"activeCount":97},[],{"trials":1920,"activeCount":97},[],{"trials":1922,"activeCount":97},[],{"trials":1924,"activeCount":97},[],{"trials":1926,"activeCount":97},[1927],{"nctId":1884,"briefTitle":1885,"status":1011,"phases":1928,"primaryCompletion":1887,"completion":1887,"start":1888,"enrollment":1889,"conditions":1929,"interventions":1930},[89],[1891],[1871,1893,1894],{"trials":1932,"activeCount":97},[],{"intervention":1934,"totalTrials":93,"cells":1935},"Antibiotics, cefuroxime and metronidazole",{"EARLY_PHASE1":1936,"PHASE1":1938,"PHASE2":1940,"PHASE3":1942,"PHASE4":1944,"NA":1957},{"trials":1937,"activeCount":97},[],{"trials":1939,"activeCount":97},[],{"trials":1941,"activeCount":97},[],{"trials":1943,"activeCount":97},[],{"trials":1945,"activeCount":97},[1946],{"nctId":1947,"briefTitle":1948,"status":1011,"phases":1949,"primaryCompletion":1950,"completion":1951,"start":1952,"enrollment":1953,"conditions":1954,"interventions":1955},"NCT04378868","Role of Delay and Antibiotics on Perforation Rate While Waiting Appendectomy",[89],"2023-01-23","2023-02-23","2020-05-18",1800,[23],[1934,1956],"No antibiotics",{"trials":1958,"activeCount":97},[],{"intervention":1956,"totalTrials":93,"cells":1960},{"EARLY_PHASE1":1961,"PHASE1":1963,"PHASE2":1965,"PHASE3":1967,"PHASE4":1969,"NA":1975},{"trials":1962,"activeCount":97},[],{"trials":1964,"activeCount":97},[],{"trials":1966,"activeCount":97},[],{"trials":1968,"activeCount":97},[],{"trials":1970,"activeCount":97},[1971],{"nctId":1947,"briefTitle":1948,"status":1011,"phases":1972,"primaryCompletion":1950,"completion":1951,"start":1952,"enrollment":1953,"conditions":1973,"interventions":1974},[89],[23],[1934,1956],{"trials":1976,"activeCount":97},[],{"intervention":1978,"totalTrials":93,"cells":1979},"PCC",{"EARLY_PHASE1":1980,"PHASE1":1982,"PHASE2":1984,"PHASE3":1986,"PHASE4":1988,"NA":2001},{"trials":1981,"activeCount":97},[],{"trials":1983,"activeCount":97},[],{"trials":1985,"activeCount":97},[],{"trials":1987,"activeCount":97},[],{"trials":1989,"activeCount":97},[1990],{"nctId":1991,"briefTitle":1992,"status":1993,"phases":1994,"primaryCompletion":1995,"completion":1995,"start":1996,"enrollment":97,"conditions":1997,"interventions":1999},"NCT01910675","PCC and Fibrinogen Compared With FFP in PPH","WITHDRAWN",[89],"2018-10","2013-07",[1998],"Postpartum Haemorrhage",[1978,2000],"FFP",{"trials":2002,"activeCount":97},[],{"intervention":2000,"totalTrials":93,"cells":2004},{"EARLY_PHASE1":2005,"PHASE1":2007,"PHASE2":2009,"PHASE3":2011,"PHASE4":2013,"NA":2019},{"trials":2006,"activeCount":97},[],{"trials":2008,"activeCount":97},[],{"trials":2010,"activeCount":97},[],{"trials":2012,"activeCount":97},[],{"trials":2014,"activeCount":97},[2015],{"nctId":1991,"briefTitle":1992,"status":1993,"phases":2016,"primaryCompletion":1995,"completion":1995,"start":1996,"enrollment":97,"conditions":2017,"interventions":2018},[89],[1998],[1978,2000],{"trials":2020,"activeCount":97},[],{"intervention":2022,"totalTrials":93,"cells":2023},"Oxynorm on-demand",{"EARLY_PHASE1":2024,"PHASE1":2026,"PHASE2":2028,"PHASE3":2030,"PHASE4":2032,"NA":2046},{"trials":2025,"activeCount":97},[],{"trials":2027,"activeCount":97},[],{"trials":2029,"activeCount":97},[],{"trials":2031,"activeCount":97},[],{"trials":2033,"activeCount":97},[2034],{"nctId":2035,"briefTitle":2036,"status":1011,"phases":2037,"primaryCompletion":2038,"completion":2039,"start":2040,"enrollment":2041,"conditions":2042,"interventions":2044},"NCT02678897","Pain and Medical Abortion Among Teenaged Women Compared to Adult Women",[89],"2018-08","2018-08-31","2016-03",242,[2043],"Pain",[2022,2045],"Oxynorm via PCA",{"trials":2047,"activeCount":97},[],{"intervention":2045,"totalTrials":93,"cells":2049},{"EARLY_PHASE1":2050,"PHASE1":2052,"PHASE2":2054,"PHASE3":2056,"PHASE4":2058,"NA":2064},{"trials":2051,"activeCount":97},[],{"trials":2053,"activeCount":97},[],{"trials":2055,"activeCount":97},[],{"trials":2057,"activeCount":97},[],{"trials":2059,"activeCount":97},[2060],{"nctId":2035,"briefTitle":2036,"status":1011,"phases":2061,"primaryCompletion":2038,"completion":2039,"start":2040,"enrollment":2041,"conditions":2062,"interventions":2063},[89],[2043],[2022,2045],{"trials":2065,"activeCount":97},[],{"intervention":1033,"totalTrials":93,"cells":2067},{"EARLY_PHASE1":2068,"PHASE1":2070,"PHASE2":2072,"PHASE3":2074,"PHASE4":2076,"NA":2082},{"trials":2069,"activeCount":97},[],{"trials":2071,"activeCount":97},[],{"trials":2073,"activeCount":97},[],{"trials":2075,"activeCount":97},[],{"trials":2077,"activeCount":97},[2078],{"nctId":1023,"briefTitle":1024,"status":1011,"phases":2079,"primaryCompletion":1026,"completion":1026,"start":1027,"enrollment":1028,"conditions":2080,"interventions":2081},[89],[1030,1031],[996,1033],{"trials":2083,"activeCount":97},[],{"intervention":2085,"totalTrials":93,"cells":2086},"Hydroxychloroquine",{"EARLY_PHASE1":2087,"PHASE1":2089,"PHASE2":2091,"PHASE3":2093,"PHASE4":2095,"NA":2110},{"trials":2088,"activeCount":97},[],{"trials":2090,"activeCount":97},[],{"trials":2092,"activeCount":97},[],{"trials":2094,"activeCount":97},[],{"trials":2096,"activeCount":97},[2097],{"nctId":2098,"briefTitle":2099,"status":1011,"phases":2100,"primaryCompletion":1508,"completion":1508,"start":2101,"enrollment":2102,"conditions":2103,"interventions":2109},"NCT02648464","Hydroxychloroquine for the Prevention of Cardiovascular Events in Myocardial Infarction Patients - a Safety Pilot Trial",[89],"2016-02-01",125,[2104,2105,2106,2085,2107,2108],"Myocardial Infarction","Acute Coronary Syndrome","Inflammation","Antirheumatic Agents","Cardiovascular Diseases",[2085],{"trials":2111,"activeCount":97},[],{"intervention":2113,"totalTrials":93,"cells":2114},"neomycin, metronidazole, polyethylene glycol",{"EARLY_PHASE1":2115,"PHASE1":2117,"PHASE2":2119,"PHASE3":2121,"PHASE4":2123,"NA":2135},{"trials":2116,"activeCount":97},[],{"trials":2118,"activeCount":97},[],{"trials":2120,"activeCount":97},[],{"trials":2122,"activeCount":97},[],{"trials":2124,"activeCount":97},[2125],{"nctId":2126,"briefTitle":2127,"status":306,"phases":2128,"primaryCompletion":2129,"completion":2130,"start":2040,"enrollment":2131,"conditions":2132,"interventions":2134},"NCT02652637","MOBILE Trial. Mechanical and Oral Antibiotic Bowel Preparation Versus no Bowel preparatIon for eLEctive Colectomy - a Multicenter, Prospective, Randomized, Controlled Trial.",[89],"2018-09","2023-08",417,[2133],"Colorectal Surgery",[2113],{"trials":2136,"activeCount":97},[],{"intervention":2138,"totalTrials":93,"cells":2139},"Doxapram",{"EARLY_PHASE1":2140,"PHASE1":2142,"PHASE2":2144,"PHASE3":2146,"PHASE4":2148,"NA":2160},{"trials":2141,"activeCount":97},[],{"trials":2143,"activeCount":97},[],{"trials":2145,"activeCount":97},[],{"trials":2147,"activeCount":97},[],{"trials":2149,"activeCount":97},[2150],{"nctId":2151,"briefTitle":2152,"status":1011,"phases":2153,"primaryCompletion":2154,"completion":2154,"start":2155,"enrollment":1687,"conditions":2156,"interventions":2159},"NCT02171910","Doxapram as an Additive to Propofol Sedation in Sedation for ERCP",[89],"2016-12","2016-10",[2157,2158],"Sedation","Hypoxia",[2138],{"trials":2161,"activeCount":97},[],{"intervention":2163,"totalTrials":93,"cells":2164},"Tiotropium Bromide",{"EARLY_PHASE1":2165,"PHASE1":2167,"PHASE2":2169,"PHASE3":2171,"PHASE4":2173,"NA":2189},{"trials":2166,"activeCount":97},[],{"trials":2168,"activeCount":97},[],{"trials":2170,"activeCount":97},[],{"trials":2172,"activeCount":97},[],{"trials":2174,"activeCount":97},[2175],{"nctId":2176,"briefTitle":2177,"status":1506,"phases":2178,"primaryCompletion":2179,"completion":2179,"start":2180,"enrollment":1264,"conditions":2181,"interventions":2186},"NCT03199976","Efficacy of Intermittent Tiotropium in Early Childhood Wheezing",[89],"2020-11-18","2016-04-20",[2182,2183,2184,2185],"Wheezy Bronchitis","Asthmatic Bronchitis","Wheezing","Obstruction Airway",[2163,2187,2188],"Fluticasone Propionate","Salbutamol",{"trials":2190,"activeCount":97},[],{"intervention":2187,"totalTrials":93,"cells":2192},{"EARLY_PHASE1":2193,"PHASE1":2195,"PHASE2":2197,"PHASE3":2199,"PHASE4":2201,"NA":2207},{"trials":2194,"activeCount":97},[],{"trials":2196,"activeCount":97},[],{"trials":2198,"activeCount":97},[],{"trials":2200,"activeCount":97},[],{"trials":2202,"activeCount":97},[2203],{"nctId":2176,"briefTitle":2177,"status":1506,"phases":2204,"primaryCompletion":2179,"completion":2179,"start":2180,"enrollment":1264,"conditions":2205,"interventions":2206},[89],[2182,2183,2184,2185],[2163,2187,2188],{"trials":2208,"activeCount":97},[],{"intervention":2188,"totalTrials":93,"cells":2210},{"EARLY_PHASE1":2211,"PHASE1":2213,"PHASE2":2215,"PHASE3":2217,"PHASE4":2219,"NA":2225},{"trials":2212,"activeCount":97},[],{"trials":2214,"activeCount":97},[],{"trials":2216,"activeCount":97},[],{"trials":2218,"activeCount":97},[],{"trials":2220,"activeCount":97},[2221],{"nctId":2176,"briefTitle":2177,"status":1506,"phases":2222,"primaryCompletion":2179,"completion":2179,"start":2180,"enrollment":1264,"conditions":2223,"interventions":2224},[89],[2182,2183,2184,2185],[2163,2187,2188],{"trials":2226,"activeCount":97},[],{"intervention":2228,"totalTrials":93,"cells":2229},"Liraglutide",{"EARLY_PHASE1":2230,"PHASE1":2232,"PHASE2":2234,"PHASE3":2236,"PHASE4":2238,"NA":2250},{"trials":2231,"activeCount":97},[],{"trials":2233,"activeCount":97},[],{"trials":2235,"activeCount":97},[],{"trials":2237,"activeCount":97},[],{"trials":2239,"activeCount":97},[2240],{"nctId":2241,"briefTitle":2242,"status":1011,"phases":2243,"primaryCompletion":2244,"completion":2244,"start":2245,"enrollment":2246,"conditions":2247,"interventions":2249},"NCT02765399","The Effect of Liraglutide Treatment on Postprandial Chylomicron and VLDL Kinetics, Liver Fat and de Novo Lipogenesis",[89],"2019-02-28","2015-02-01",23,[2248],"Type 2 Diabetes",[2228],{"trials":2251,"activeCount":97},[],{"intervention":2253,"totalTrials":93,"cells":2254},"Testosterone",{"EARLY_PHASE1":2255,"PHASE1":2257,"PHASE2":2259,"PHASE3":2261,"PHASE4":2274,"NA":2276},{"trials":2256,"activeCount":97},[],{"trials":2258,"activeCount":97},[],{"trials":2260,"activeCount":97},[],{"trials":2262,"activeCount":97},[2263],{"nctId":2264,"briefTitle":2265,"status":1011,"phases":2266,"primaryCompletion":2267,"completion":2268,"start":1150,"enrollment":2269,"conditions":2270,"interventions":2272},"NCT01797718","Constitutional Delay of Growth and Puberty: Towards Evidence-based Treatment",[87,88],"2017-03-20","2018-02-05",35,[2271],"Constitutional Delay of Growth and Puberty",[2253,2273],"Letrozole",{"trials":2275,"activeCount":97},[],{"trials":2277,"activeCount":97},[],{"intervention":2273,"totalTrials":93,"cells":2279},{"EARLY_PHASE1":2280,"PHASE1":2282,"PHASE2":2284,"PHASE3":2286,"PHASE4":2292,"NA":2294},{"trials":2281,"activeCount":97},[],{"trials":2283,"activeCount":97},[],{"trials":2285,"activeCount":97},[],{"trials":2287,"activeCount":97},[2288],{"nctId":2264,"briefTitle":2265,"status":1011,"phases":2289,"primaryCompletion":2267,"completion":2268,"start":1150,"enrollment":2269,"conditions":2290,"interventions":2291},[87,88],[2271],[2253,2273],{"trials":2293,"activeCount":97},[],{"trials":2295,"activeCount":97},[],{"intervention":2297,"totalTrials":93,"cells":2298},"Filgrastim",{"EARLY_PHASE1":2299,"PHASE1":2301,"PHASE2":2303,"PHASE3":2305,"PHASE4":2317,"NA":2319},{"trials":2300,"activeCount":97},[],{"trials":2302,"activeCount":97},[],{"trials":2304,"activeCount":97},[],{"trials":2306,"activeCount":97},[2307],{"nctId":2308,"briefTitle":2309,"status":1011,"phases":2310,"primaryCompletion":2311,"completion":2312,"start":2313,"enrollment":1889,"conditions":2314,"interventions":2316},"NCT01713309","Heparin Binding Protein in Patients With Acute Respiratory Failure Treated With GCSF (Filgrastim)",[87,88],"1998-06","1998-09","1996-01",[2315,28],"Acute Respiratory Failure",[2297],{"trials":2318,"activeCount":97},[],{"trials":2320,"activeCount":97},[],{"intervention":2322,"totalTrials":93,"cells":2323},"Mouse brain derived japanese encephalitis vaccine",{"EARLY_PHASE1":2324,"PHASE1":2326,"PHASE2":2328,"PHASE3":2330,"PHASE4":2344,"NA":2346},{"trials":2325,"activeCount":97},[],{"trials":2327,"activeCount":97},[],{"trials":2329,"activeCount":97},[],{"trials":2331,"activeCount":97},[2332],{"nctId":2333,"briefTitle":2334,"status":1011,"phases":2335,"primaryCompletion":2336,"completion":2336,"start":2337,"enrollment":1328,"conditions":2338,"interventions":2340},"NCT01386827","Ixiaro as Booster After Mouse-brain Derived Vaccines for Japanese Encephalitis",[88],"2011-04","2008-01",[2339],"Japanese Encephalitis",[2322,2341,2342,2343],"Primary and booster immunizations with MB-JEV","C) primary immunizations with Ixiaro","S) Ixiaro booster to MBJEV primed",{"trials":2345,"activeCount":97},[],{"trials":2347,"activeCount":97},[],{"intervention":2341,"totalTrials":93,"cells":2349},{"EARLY_PHASE1":2350,"PHASE1":2352,"PHASE2":2354,"PHASE3":2356,"PHASE4":2362,"NA":2364},{"trials":2351,"activeCount":97},[],{"trials":2353,"activeCount":97},[],{"trials":2355,"activeCount":97},[],{"trials":2357,"activeCount":97},[2358],{"nctId":2333,"briefTitle":2334,"status":1011,"phases":2359,"primaryCompletion":2336,"completion":2336,"start":2337,"enrollment":1328,"conditions":2360,"interventions":2361},[88],[2339],[2322,2341,2342,2343],{"trials":2363,"activeCount":97},[],{"trials":2365,"activeCount":97},[],{"intervention":2342,"totalTrials":93,"cells":2367},{"EARLY_PHASE1":2368,"PHASE1":2370,"PHASE2":2372,"PHASE3":2374,"PHASE4":2380,"NA":2382},{"trials":2369,"activeCount":97},[],{"trials":2371,"activeCount":97},[],{"trials":2373,"activeCount":97},[],{"trials":2375,"activeCount":97},[2376],{"nctId":2333,"briefTitle":2334,"status":1011,"phases":2377,"primaryCompletion":2336,"completion":2336,"start":2337,"enrollment":1328,"conditions":2378,"interventions":2379},[88],[2339],[2322,2341,2342,2343],{"trials":2381,"activeCount":97},[],{"trials":2383,"activeCount":97},[],{"intervention":2343,"totalTrials":93,"cells":2385},{"EARLY_PHASE1":2386,"PHASE1":2388,"PHASE2":2390,"PHASE3":2392,"PHASE4":2398,"NA":2400},{"trials":2387,"activeCount":97},[],{"trials":2389,"activeCount":97},[],{"trials":2391,"activeCount":97},[],{"trials":2393,"activeCount":97},[2394],{"nctId":2333,"briefTitle":2334,"status":1011,"phases":2395,"primaryCompletion":2336,"completion":2336,"start":2337,"enrollment":1328,"conditions":2396,"interventions":2397},[88],[2339],[2322,2341,2342,2343],{"trials":2399,"activeCount":97},[],{"trials":2401,"activeCount":97},[],{"intervention":2403,"totalTrials":93,"cells":2404},"Simvastatin 80mg",{"EARLY_PHASE1":2405,"PHASE1":2407,"PHASE2":2409,"PHASE3":2411,"PHASE4":2427,"NA":2429},{"trials":2406,"activeCount":97},[],{"trials":2408,"activeCount":97},[],{"trials":2410,"activeCount":97},[],{"trials":2412,"activeCount":97},[2413],{"nctId":2414,"briefTitle":2415,"status":1011,"phases":2416,"primaryCompletion":2417,"completion":2417,"start":2418,"enrollment":2419,"conditions":2420,"interventions":2425},"NCT01160978","Donor Simvastatin Treatment in Organ Transplantation",[87,88],"2016-08-01","2010-06-01",84,[2421,2422,2423,780,2424],"Heart Failure","Respiratory Failure","Liver Failure","Transplantation",[2403,2426],"Control Rx",{"trials":2428,"activeCount":97},[],{"trials":2430,"activeCount":97},[],{"intervention":2426,"totalTrials":93,"cells":2432},{"EARLY_PHASE1":2433,"PHASE1":2435,"PHASE2":2437,"PHASE3":2439,"PHASE4":2445,"NA":2447},{"trials":2434,"activeCount":97},[],{"trials":2436,"activeCount":97},[],{"trials":2438,"activeCount":97},[],{"trials":2440,"activeCount":97},[2441],{"nctId":2414,"briefTitle":2415,"status":1011,"phases":2442,"primaryCompletion":2417,"completion":2417,"start":2418,"enrollment":2419,"conditions":2443,"interventions":2444},[87,88],[2421,2422,2423,780,2424],[2403,2426],{"trials":2446,"activeCount":97},[],{"trials":2448,"activeCount":97},[],{"intervention":2450,"totalTrials":93,"cells":2451},"Dexmedetomidine",{"EARLY_PHASE1":2452,"PHASE1":2454,"PHASE2":2456,"PHASE3":2458,"PHASE4":2468,"NA":2470},{"trials":2453,"activeCount":97},[],{"trials":2455,"activeCount":97},[],{"trials":2457,"activeCount":97},[],{"trials":2459,"activeCount":97},[2460],{"nctId":2461,"briefTitle":2462,"status":306,"phases":2463,"primaryCompletion":2464,"start":1554,"enrollment":1555,"conditions":2465,"interventions":2467},"NCT01314209","Dexmedetomidine Pharmacokinetics During Continuous Renal Replacement Therapy (CRRT)",[87,88],"2014-03",[2466],"Acute Kidney Injury",[2450],{"trials":2469,"activeCount":97},[],{"trials":2471,"activeCount":97},[],{"intervention":2473,"totalTrials":93,"cells":2474},"Infliximab plus methotrexate",{"EARLY_PHASE1":2475,"PHASE1":2477,"PHASE2":2479,"PHASE3":2481,"PHASE4":2496,"NA":2498},{"trials":2476,"activeCount":97},[],{"trials":2478,"activeCount":97},[],{"trials":2480,"activeCount":97},[],{"trials":2482,"activeCount":97},[2483],{"nctId":2484,"briefTitle":2485,"status":1011,"phases":2486,"primaryCompletion":2487,"completion":2488,"start":2489,"enrollment":2490,"conditions":2491,"interventions":2493},"NCT01015547","Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis",[88],"2007-11","2013-12","2003-05",60,[2492],"Juvenile Idiopathic Arthritis",[2473,2494,2495],"Combination of DMARDs","Methotrexate alone",{"trials":2497,"activeCount":97},[],{"trials":2499,"activeCount":97},[],{"intervention":2494,"totalTrials":93,"cells":2501},{"EARLY_PHASE1":2502,"PHASE1":2504,"PHASE2":2506,"PHASE3":2508,"PHASE4":2514,"NA":2516},{"trials":2503,"activeCount":97},[],{"trials":2505,"activeCount":97},[],{"trials":2507,"activeCount":97},[],{"trials":2509,"activeCount":97},[2510],{"nctId":2484,"briefTitle":2485,"status":1011,"phases":2511,"primaryCompletion":2487,"completion":2488,"start":2489,"enrollment":2490,"conditions":2512,"interventions":2513},[88],[2492],[2473,2494,2495],{"trials":2515,"activeCount":97},[],{"trials":2517,"activeCount":97},[],{"intervention":2495,"totalTrials":93,"cells":2519},{"EARLY_PHASE1":2520,"PHASE1":2522,"PHASE2":2524,"PHASE3":2526,"PHASE4":2532,"NA":2534},{"trials":2521,"activeCount":97},[],{"trials":2523,"activeCount":97},[],{"trials":2525,"activeCount":97},[],{"trials":2527,"activeCount":97},[2528],{"nctId":2484,"briefTitle":2485,"status":1011,"phases":2529,"primaryCompletion":2487,"completion":2488,"start":2489,"enrollment":2490,"conditions":2530,"interventions":2531},[88],[2492],[2473,2494,2495],{"trials":2533,"activeCount":97},[],{"trials":2535,"activeCount":97},[],{"intervention":2537,"totalTrials":93,"cells":2538},"Intravaginal estrogen during adjuvant letrozole",{"EARLY_PHASE1":2539,"PHASE1":2541,"PHASE2":2543,"PHASE3":2554,"PHASE4":2556,"NA":2558},{"trials":2540,"activeCount":97},[],{"trials":2542,"activeCount":97},[],{"trials":2544,"activeCount":97},[2545],{"nctId":2546,"briefTitle":2547,"status":1011,"phases":2548,"primaryCompletion":2549,"completion":2549,"start":2550,"enrollment":2551,"conditions":2552,"interventions":2553},"NCT06654570","Effects of Vaginal Estrogen on Serum Estradiol During Aromatase Inhibitor Therapy in Breast Cancer Patients with Vulvovaginal Atrophy: a Prospective Trial",[87],"2024-10-10","2020-04-08",20,[424],[2537],{"trials":2555,"activeCount":97},[],{"trials":2557,"activeCount":97},[],{"trials":2559,"activeCount":97},[],{"intervention":2561,"totalTrials":93,"cells":2562},"Fecal microbiota transplantation",{"EARLY_PHASE1":2563,"PHASE1":2565,"PHASE2":2567,"PHASE3":2580,"PHASE4":2582,"NA":2584},{"trials":2564,"activeCount":97},[],{"trials":2566,"activeCount":97},[],{"trials":2568,"activeCount":97},[2569],{"nctId":2570,"briefTitle":2571,"status":1011,"phases":2572,"primaryCompletion":2573,"completion":2573,"start":2574,"enrollment":2575,"conditions":2576,"interventions":2579},"NCT03378921","Fecal Microbiota Transplantation (FMT) in the Treatment of Pouchitis",[87],"2019-09-25","2018-02-27",26,[2577,2578],"Pouchitis","Ulcerative Colitis",[2561],{"trials":2581,"activeCount":97},[],{"trials":2583,"activeCount":97},[],{"trials":2585,"activeCount":97},[],{"intervention":2587,"totalTrials":93,"cells":2588},"Thalidomide, etoposide, celecoxib",{"EARLY_PHASE1":2589,"PHASE1":2591,"PHASE2":2593,"PHASE3":2602,"PHASE4":2604,"NA":2606},{"trials":2590,"activeCount":97},[],{"trials":2592,"activeCount":97},[],{"trials":2594,"activeCount":97},[2595],{"nctId":2596,"briefTitle":2597,"status":1011,"phases":2598,"primaryCompletion":2488,"completion":2488,"start":1730,"enrollment":1687,"conditions":2599,"interventions":2601},"NCT01756989","ANGIOCOMB Antiangiogenic Therapy for Pediatric Patients With Diffuse Brain Stem and Thalamic Tumors",[87],[2600],"Brainstem Glioma",[2587],{"trials":2603,"activeCount":97},[],{"trials":2605,"activeCount":97},[],{"trials":2607,"activeCount":97},[],{"intervention":2609,"totalTrials":93,"cells":2610},"Venetoclax",{"EARLY_PHASE1":2611,"PHASE1":2613,"PHASE2":2615,"PHASE3":2627,"PHASE4":2629,"NA":2631},{"trials":2612,"activeCount":97},[],{"trials":2614,"activeCount":97},[],{"trials":2616,"activeCount":97},[2617],{"nctId":2618,"briefTitle":2619,"status":1011,"phases":2620,"primaryCompletion":2621,"completion":2621,"start":2622,"enrollment":2623,"conditions":2624,"interventions":2626},"NCT04267081","Study of Venetoclax in Combination With Azacytidine in AML Patients Selected Using Ex Vivo Drug Sensitivity Screening",[87],"2024-02-28","2020-02-12",104,[2625],"Acute Myeloid Leukemia",[2609],{"trials":2628,"activeCount":97},[],{"trials":2630,"activeCount":97},[],{"trials":2632,"activeCount":97},[],{"intervention":2634,"totalTrials":93,"cells":2635},"Convalescent plasma from COVID-19 donors",{"EARLY_PHASE1":2636,"PHASE1":2638,"PHASE2":2640,"PHASE3":2653,"PHASE4":2655,"NA":2657},{"trials":2637,"activeCount":97},[],{"trials":2639,"activeCount":97},[],{"trials":2641,"activeCount":97},[2642],{"nctId":2643,"briefTitle":2644,"status":306,"phases":2645,"primaryCompletion":2646,"completion":2647,"start":2648,"enrollment":2649,"conditions":2650,"interventions":2652},"NCT04730401","Convalescent Plasma in the Treatment of Covid-19",[87],"2022-01-30","2023-01-30","2021-01-27",390,[2651],"Covid19",[2634],{"trials":2654,"activeCount":97},[],{"trials":2656,"activeCount":97},[],{"trials":2658,"activeCount":97},[],{"intervention":2660,"totalTrials":93,"cells":2661},"Esketamine Nasal Spray",{"EARLY_PHASE1":2662,"PHASE1":2664,"PHASE2":2678,"PHASE3":2680,"PHASE4":2682,"NA":2684},{"trials":2663,"activeCount":97},[],{"trials":2665,"activeCount":97},[2666],{"nctId":2667,"briefTitle":2668,"status":1011,"phases":2669,"primaryCompletion":2670,"completion":2670,"start":2671,"enrollment":799,"conditions":2672,"interventions":2675},"NCT06726382","KF2024#1-trial: Esketamine Interaction Study",[86],"2025-04-29","2024-12-09",[2673,2674],"Drug Interactions","Food-drug Interaction",[2660,2676,2677],"Esketamine 28 mg","Cobicistat 150 MG",{"trials":2679,"activeCount":97},[],{"trials":2681,"activeCount":97},[],{"trials":2683,"activeCount":97},[],{"trials":2685,"activeCount":97},[],{"intervention":2676,"totalTrials":93,"cells":2687},{"EARLY_PHASE1":2688,"PHASE1":2690,"PHASE2":2696,"PHASE3":2698,"PHASE4":2700,"NA":2702},{"trials":2689,"activeCount":97},[],{"trials":2691,"activeCount":97},[2692],{"nctId":2667,"briefTitle":2668,"status":1011,"phases":2693,"primaryCompletion":2670,"completion":2670,"start":2671,"enrollment":799,"conditions":2694,"interventions":2695},[86],[2673,2674],[2660,2676,2677],{"trials":2697,"activeCount":97},[],{"trials":2699,"activeCount":97},[],{"trials":2701,"activeCount":97},[],{"trials":2703,"activeCount":97},[],{"intervention":2677,"totalTrials":93,"cells":2705},{"EARLY_PHASE1":2706,"PHASE1":2708,"PHASE2":2714,"PHASE3":2716,"PHASE4":2718,"NA":2720},{"trials":2707,"activeCount":97},[],{"trials":2709,"activeCount":97},[2710],{"nctId":2667,"briefTitle":2668,"status":1011,"phases":2711,"primaryCompletion":2670,"completion":2670,"start":2671,"enrollment":799,"conditions":2712,"interventions":2713},[86],[2673,2674],[2660,2676,2677],{"trials":2715,"activeCount":97},[],{"trials":2717,"activeCount":97},[],{"trials":2719,"activeCount":97},[],{"trials":2721,"activeCount":97},[],{"intervention":2723,"totalTrials":93,"cells":2724},"Risperidone oral solution",{"EARLY_PHASE1":2725,"PHASE1":2727,"PHASE2":2738,"PHASE3":2740,"PHASE4":2742,"NA":2744},{"trials":2726,"activeCount":97},[],{"trials":2728,"activeCount":97},[2729],{"nctId":2730,"briefTitle":2731,"status":1011,"phases":2732,"primaryCompletion":2733,"completion":2733,"start":2734,"enrollment":799,"conditions":2735,"interventions":2737},"NCT06218979","KF2022#3-trial: Effect of Tea and Cola Beverage on Absorption of Risperidone Oral Solution",[86],"2024-03-14","2023-12-08",[2736,2674],"Psychosis",[2723],{"trials":2739,"activeCount":97},[],{"trials":2741,"activeCount":97},[],{"trials":2743,"activeCount":97},[],{"trials":2745,"activeCount":97},[],{"intervention":2747,"totalTrials":93,"cells":2748},"Ticagrelor",{"EARLY_PHASE1":2749,"PHASE1":2751,"PHASE2":2763,"PHASE3":2765,"PHASE4":2767,"NA":2769},{"trials":2750,"activeCount":97},[],{"trials":2752,"activeCount":97},[2753],{"nctId":2754,"briefTitle":2755,"status":306,"phases":2756,"primaryCompletion":2757,"completion":2757,"start":2758,"enrollment":1555,"conditions":2759,"interventions":2761},"NCT05373277","KF2019#1-trial: Effects of a Thrombocyte Inhibitor on a Cholesterol-lowering Drug",[86],"2022-12-31","2022-05-11",[2760],"Pharmacokinetics",[2747,2762],"Rosuvastatin",{"trials":2764,"activeCount":97},[],{"trials":2766,"activeCount":97},[],{"trials":2768,"activeCount":97},[],{"trials":2770,"activeCount":97},[],{"intervention":2762,"totalTrials":93,"cells":2772},{"EARLY_PHASE1":2773,"PHASE1":2775,"PHASE2":2781,"PHASE3":2783,"PHASE4":2785,"NA":2787},{"trials":2774,"activeCount":97},[],{"trials":2776,"activeCount":97},[2777],{"nctId":2754,"briefTitle":2755,"status":306,"phases":2778,"primaryCompletion":2757,"completion":2757,"start":2758,"enrollment":1555,"conditions":2779,"interventions":2780},[86],[2760],[2747,2762],{"trials":2782,"activeCount":97},[],{"trials":2784,"activeCount":97},[],{"trials":2786,"activeCount":97},[],{"trials":2788,"activeCount":97},[],{"intervention":1268,"totalTrials":285,"cells":2790},{"EARLY_PHASE1":2791,"PHASE1":2793,"PHASE2":2795,"PHASE3":2797,"PHASE4":2799,"NA":2805},{"trials":2792,"activeCount":97},[],{"trials":2794,"activeCount":97},[],{"trials":2796,"activeCount":97},[],{"trials":2798,"activeCount":97},[],{"trials":2800,"activeCount":97},[2801],{"nctId":1259,"briefTitle":1260,"status":1011,"phases":2802,"primaryCompletion":1262,"completion":1262,"start":1263,"enrollment":1264,"conditions":2803,"interventions":2804},[89],[1266],[1268,1246,1269,1270],{"trials":2806,"activeCount":97},[2807],{"nctId":2808,"briefTitle":2809,"status":1011,"phases":2810,"primaryCompletion":2811,"completion":2811,"start":2812,"enrollment":1821,"conditions":2813,"interventions":2814},"NCT03250481","Responsiveness Index Versus the RASS Based Method for Adjusting Sedation in Critically Ill Patients",[90],"2017-08-28","2013-03",[20],[2815],"Propofol",{"intervention":2817,"totalTrials":285,"cells":2818},"Diclofenac",{"EARLY_PHASE1":2819,"PHASE1":2821,"PHASE2":2823,"PHASE3":2825,"PHASE4":2827,"NA":2829},{"trials":2820,"activeCount":97},[],{"trials":2822,"activeCount":97},[],{"trials":2824,"activeCount":97},[],{"trials":2826,"activeCount":97},[],{"trials":2828,"activeCount":97},[],{"trials":2830,"activeCount":97},[2831,2841],{"nctId":2832,"briefTitle":2833,"status":1011,"phases":2834,"primaryCompletion":2835,"completion":2835,"start":2836,"enrollment":778,"conditions":2837,"interventions":2839},"NCT01541137","NSAIDs With Morphine-PCA Compared to Epidural Analgesia in Thoracotomy Pain",[90],"2008-09","2004-03",[2838],"Postoperative Pain",[2817,2840],"parecoxib\u002F valdecoxib",{"nctId":2842,"briefTitle":2843,"status":1011,"phases":2844,"primaryCompletion":2845,"completion":2845,"start":2846,"enrollment":799,"conditions":2847,"interventions":2849},"NCT06566794","KF2022#4-trial: Effects of a Beta Blocker and NSAID on CYP Mediated Drug Metabolism",[90],"2025-01-10","2024-08-22",[2848],"Drug Interaction",[2850,2851,2852,2853,2854,2855,2856,2857,2858,2817],"Caffeine","Bupropion Hydrochloride Capsels","Repaglinide Capsels","Flurbiprofen Capsels","Omeprazole 10 MG","Dextromethorphan Oral Solution","Midazolam oral solution","Simvastatin","Carvedilol",{"intervention":2860,"totalTrials":93,"cells":2861},"birch pollen subcutaneous immunotherapy",{"EARLY_PHASE1":2862,"PHASE1":2864,"PHASE2":2866,"PHASE3":2868,"PHASE4":2870,"NA":2872},{"trials":2863,"activeCount":97},[],{"trials":2865,"activeCount":97},[],{"trials":2867,"activeCount":97},[],{"trials":2869,"activeCount":97},[],{"trials":2871,"activeCount":97},[],{"trials":2873,"activeCount":97},[2874],{"nctId":2875,"briefTitle":2876,"status":1011,"phases":2877,"primaryCompletion":1193,"completion":1193,"start":1194,"enrollment":2878,"conditions":2879,"interventions":2881},"NCT01985542","The Effects of Immunotherapy in the Nose",[90],16,[2880],"Rhinitis, Allergic, Seasonal",[2860],{"intervention":2883,"totalTrials":93,"cells":2884},"Pasireotide 0.9 MG\u002FML",{"EARLY_PHASE1":2885,"PHASE1":2887,"PHASE2":2889,"PHASE3":2891,"PHASE4":2893,"NA":2895},{"trials":2886,"activeCount":97},[],{"trials":2888,"activeCount":97},[],{"trials":2890,"activeCount":97},[],{"trials":2892,"activeCount":97},[],{"trials":2894,"activeCount":97},[],{"trials":2896,"activeCount":97},[2897],{"nctId":2898,"briefTitle":2899,"status":1011,"phases":2900,"primaryCompletion":2901,"completion":2901,"start":2902,"enrollment":2903,"conditions":2904,"interventions":2906},"NCT04281680","Impact of Pasireotide on Postoperative Pancreatic Fistulas Following Distal Resections",[],"2016-04-30","2014-07-01",258,[2905],"Surgical Complications",[2883],{"intervention":2908,"totalTrials":93,"cells":2909},"Femoral nerve blockade",{"EARLY_PHASE1":2910,"PHASE1":2912,"PHASE2":2914,"PHASE3":2916,"PHASE4":2918,"NA":2920},{"trials":2911,"activeCount":97},[],{"trials":2913,"activeCount":97},[],{"trials":2915,"activeCount":97},[],{"trials":2917,"activeCount":97},[],{"trials":2919,"activeCount":97},[],{"trials":2921,"activeCount":97},[2922],{"nctId":2923,"briefTitle":2924,"status":1011,"phases":2925,"primaryCompletion":2926,"completion":2927,"start":2928,"enrollment":1264,"conditions":2929,"interventions":2930},"NCT03475641","Femoral Nerve Blockade in Endovenous Laser",[90],"2019-10-15","2021-12-31","2017-03-13",[2043],[2908],{"intervention":2840,"totalTrials":93,"cells":2932},{"EARLY_PHASE1":2933,"PHASE1":2935,"PHASE2":2937,"PHASE3":2939,"PHASE4":2941,"NA":2943},{"trials":2934,"activeCount":97},[],{"trials":2936,"activeCount":97},[],{"trials":2938,"activeCount":97},[],{"trials":2940,"activeCount":97},[],{"trials":2942,"activeCount":97},[],{"trials":2944,"activeCount":97},[2945],{"nctId":2832,"briefTitle":2833,"status":1011,"phases":2946,"primaryCompletion":2835,"completion":2835,"start":2836,"enrollment":778,"conditions":2947,"interventions":2948},[90],[2838],[2817,2840],{"intervention":2950,"totalTrials":93,"cells":2951},"Ibuprofen",{"EARLY_PHASE1":2952,"PHASE1":2954,"PHASE2":2956,"PHASE3":2958,"PHASE4":2960,"NA":2962},{"trials":2953,"activeCount":97},[],{"trials":2955,"activeCount":97},[],{"trials":2957,"activeCount":97},[],{"trials":2959,"activeCount":97},[],{"trials":2961,"activeCount":97},[],{"trials":2963,"activeCount":97},[2964],{"nctId":2965,"briefTitle":2966,"status":1011,"phases":2967,"primaryCompletion":2968,"start":2969,"enrollment":2970,"conditions":2971,"interventions":2973},"NCT02219698","Symptomatic Treatment of Acute Uncomplicated Diverticulitis",[90],"2015-07","2014-07",158,[2972],"Diverticulitis",[2950,2974],"Paracetamol",{"intervention":2974,"totalTrials":93,"cells":2976},{"EARLY_PHASE1":2977,"PHASE1":2979,"PHASE2":2981,"PHASE3":2983,"PHASE4":2985,"NA":2987},{"trials":2978,"activeCount":97},[],{"trials":2980,"activeCount":97},[],{"trials":2982,"activeCount":97},[],{"trials":2984,"activeCount":97},[],{"trials":2986,"activeCount":97},[],{"trials":2988,"activeCount":97},[2989],{"nctId":2965,"briefTitle":2966,"status":1011,"phases":2990,"primaryCompletion":2968,"start":2969,"enrollment":2970,"conditions":2991,"interventions":2992},[90],[2972],[2950,2974],{"intervention":2994,"totalTrials":93,"cells":2995},"penicillin and metronidazole in peritonsillar abscess",{"EARLY_PHASE1":2996,"PHASE1":2998,"PHASE2":3000,"PHASE3":3002,"PHASE4":3004,"NA":3006},{"trials":2997,"activeCount":97},[],{"trials":2999,"activeCount":97},[],{"trials":3001,"activeCount":97},[],{"trials":3003,"activeCount":97},[],{"trials":3005,"activeCount":97},[],{"trials":3007,"activeCount":97},[3008],{"nctId":3009,"briefTitle":3010,"status":1011,"phases":3011,"primaryCompletion":2336,"completion":2336,"start":3012,"enrollment":871,"conditions":3013,"interventions":3015},"NCT01255670","Penicillin and Metronidazole in Treatment of Peritonsillar Abscess",[90],"2010-02",[3014],"Peritonsillar Abscess",[2994],{"intervention":3017,"totalTrials":93,"cells":3018},"Whole body cryotherapy",{"EARLY_PHASE1":3019,"PHASE1":3021,"PHASE2":3023,"PHASE3":3025,"PHASE4":3027,"NA":3029},{"trials":3020,"activeCount":97},[],{"trials":3022,"activeCount":97},[],{"trials":3024,"activeCount":97},[],{"trials":3026,"activeCount":97},[],{"trials":3028,"activeCount":97},[],{"trials":3030,"activeCount":97},[3031],{"nctId":3032,"briefTitle":3033,"status":1011,"phases":3034,"primaryCompletion":3035,"completion":3035,"start":3036,"enrollment":2551,"conditions":3037,"interventions":3038},"NCT01312090","Chronic Intermittent Cold Exposure on Weight Loss",[90],"2011-06","2010-10",[15],[3017],{"intervention":3040,"totalTrials":93,"cells":3041},"Happy Bob",{"EARLY_PHASE1":3042,"PHASE1":3044,"PHASE2":3046,"PHASE3":3048,"PHASE4":3050,"NA":3052},{"trials":3043,"activeCount":97},[],{"trials":3045,"activeCount":97},[],{"trials":3047,"activeCount":97},[],{"trials":3049,"activeCount":97},[],{"trials":3051,"activeCount":97},[],{"trials":3053,"activeCount":97},[3054],{"nctId":3055,"briefTitle":3056,"status":306,"phases":3057,"primaryCompletion":3058,"completion":3058,"start":3059,"enrollment":917,"conditions":3060,"interventions":3062},"NCT05663606","Happy Bob App in 9-13 Year-old Children",[90],"2024-09","2023-06-01",[3061],"Type1diabetes",[3040],{"intervention":3064,"totalTrials":93,"cells":3065},"IL5 Antagonist or anti-IL5R-antibody or Omalizumab",{"EARLY_PHASE1":3066,"PHASE1":3068,"PHASE2":3070,"PHASE3":3072,"PHASE4":3074,"NA":3076},{"trials":3067,"activeCount":97},[],{"trials":3069,"activeCount":97},[],{"trials":3071,"activeCount":97},[],{"trials":3073,"activeCount":97},[],{"trials":3075,"activeCount":97},[],{"trials":3077,"activeCount":97},[3078],{"nctId":3079,"briefTitle":3080,"status":1011,"phases":3081,"primaryCompletion":3082,"completion":3082,"start":3083,"enrollment":3084,"conditions":3085,"interventions":3087},"NCT04158050","Comparison of Biologicals in Treatment of Severe Asthma",[],"2020-10-31","2018-01-01",64,[3086],"Asthma",[3064],{"intervention":2850,"totalTrials":93,"cells":3089},{"EARLY_PHASE1":3090,"PHASE1":3092,"PHASE2":3094,"PHASE3":3096,"PHASE4":3098,"NA":3100},{"trials":3091,"activeCount":97},[],{"trials":3093,"activeCount":97},[],{"trials":3095,"activeCount":97},[],{"trials":3097,"activeCount":97},[],{"trials":3099,"activeCount":97},[],{"trials":3101,"activeCount":97},[3102],{"nctId":2842,"briefTitle":2843,"status":1011,"phases":3103,"primaryCompletion":2845,"completion":2845,"start":2846,"enrollment":799,"conditions":3104,"interventions":3105},[90],[2848],[2850,2851,2852,2853,2854,2855,2856,2857,2858,2817],{"intervention":2851,"totalTrials":93,"cells":3107},{"EARLY_PHASE1":3108,"PHASE1":3110,"PHASE2":3112,"PHASE3":3114,"PHASE4":3116,"NA":3118},{"trials":3109,"activeCount":97},[],{"trials":3111,"activeCount":97},[],{"trials":3113,"activeCount":97},[],{"trials":3115,"activeCount":97},[],{"trials":3117,"activeCount":97},[],{"trials":3119,"activeCount":97},[3120],{"nctId":2842,"briefTitle":2843,"status":1011,"phases":3121,"primaryCompletion":2845,"completion":2845,"start":2846,"enrollment":799,"conditions":3122,"interventions":3123},[90],[2848],[2850,2851,2852,2853,2854,2855,2856,2857,2858,2817],{"intervention":2852,"totalTrials":93,"cells":3125},{"EARLY_PHASE1":3126,"PHASE1":3128,"PHASE2":3130,"PHASE3":3132,"PHASE4":3134,"NA":3136},{"trials":3127,"activeCount":97},[],{"trials":3129,"activeCount":97},[],{"trials":3131,"activeCount":97},[],{"trials":3133,"activeCount":97},[],{"trials":3135,"activeCount":97},[],{"trials":3137,"activeCount":97},[3138],{"nctId":2842,"briefTitle":2843,"status":1011,"phases":3139,"primaryCompletion":2845,"completion":2845,"start":2846,"enrollment":799,"conditions":3140,"interventions":3141},[90],[2848],[2850,2851,2852,2853,2854,2855,2856,2857,2858,2817],{"intervention":2853,"totalTrials":93,"cells":3143},{"EARLY_PHASE1":3144,"PHASE1":3146,"PHASE2":3148,"PHASE3":3150,"PHASE4":3152,"NA":3154},{"trials":3145,"activeCount":97},[],{"trials":3147,"activeCount":97},[],{"trials":3149,"activeCount":97},[],{"trials":3151,"activeCount":97},[],{"trials":3153,"activeCount":97},[],{"trials":3155,"activeCount":97},[3156],{"nctId":2842,"briefTitle":2843,"status":1011,"phases":3157,"primaryCompletion":2845,"completion":2845,"start":2846,"enrollment":799,"conditions":3158,"interventions":3159},[90],[2848],[2850,2851,2852,2853,2854,2855,2856,2857,2858,2817],{"intervention":2854,"totalTrials":93,"cells":3161},{"EARLY_PHASE1":3162,"PHASE1":3164,"PHASE2":3166,"PHASE3":3168,"PHASE4":3170,"NA":3172},{"trials":3163,"activeCount":97},[],{"trials":3165,"activeCount":97},[],{"trials":3167,"activeCount":97},[],{"trials":3169,"activeCount":97},[],{"trials":3171,"activeCount":97},[],{"trials":3173,"activeCount":97},[3174],{"nctId":2842,"briefTitle":2843,"status":1011,"phases":3175,"primaryCompletion":2845,"completion":2845,"start":2846,"enrollment":799,"conditions":3176,"interventions":3177},[90],[2848],[2850,2851,2852,2853,2854,2855,2856,2857,2858,2817],{"intervention":2855,"totalTrials":93,"cells":3179},{"EARLY_PHASE1":3180,"PHASE1":3182,"PHASE2":3184,"PHASE3":3186,"PHASE4":3188,"NA":3190},{"trials":3181,"activeCount":97},[],{"trials":3183,"activeCount":97},[],{"trials":3185,"activeCount":97},[],{"trials":3187,"activeCount":97},[],{"trials":3189,"activeCount":97},[],{"trials":3191,"activeCount":97},[3192],{"nctId":2842,"briefTitle":2843,"status":1011,"phases":3193,"primaryCompletion":2845,"completion":2845,"start":2846,"enrollment":799,"conditions":3194,"interventions":3195},[90],[2848],[2850,2851,2852,2853,2854,2855,2856,2857,2858,2817],{"intervention":2856,"totalTrials":93,"cells":3197},{"EARLY_PHASE1":3198,"PHASE1":3200,"PHASE2":3202,"PHASE3":3204,"PHASE4":3206,"NA":3208},{"trials":3199,"activeCount":97},[],{"trials":3201,"activeCount":97},[],{"trials":3203,"activeCount":97},[],{"trials":3205,"activeCount":97},[],{"trials":3207,"activeCount":97},[],{"trials":3209,"activeCount":97},[3210],{"nctId":2842,"briefTitle":2843,"status":1011,"phases":3211,"primaryCompletion":2845,"completion":2845,"start":2846,"enrollment":799,"conditions":3212,"interventions":3213},[90],[2848],[2850,2851,2852,2853,2854,2855,2856,2857,2858,2817],{"intervention":2857,"totalTrials":93,"cells":3215},{"EARLY_PHASE1":3216,"PHASE1":3218,"PHASE2":3220,"PHASE3":3222,"PHASE4":3224,"NA":3226},{"trials":3217,"activeCount":97},[],{"trials":3219,"activeCount":97},[],{"trials":3221,"activeCount":97},[],{"trials":3223,"activeCount":97},[],{"trials":3225,"activeCount":97},[],{"trials":3227,"activeCount":97},[3228],{"nctId":2842,"briefTitle":2843,"status":1011,"phases":3229,"primaryCompletion":2845,"completion":2845,"start":2846,"enrollment":799,"conditions":3230,"interventions":3231},[90],[2848],[2850,2851,2852,2853,2854,2855,2856,2857,2858,2817],{"intervention":2858,"totalTrials":93,"cells":3233},{"EARLY_PHASE1":3234,"PHASE1":3236,"PHASE2":3238,"PHASE3":3240,"PHASE4":3242,"NA":3244},{"trials":3235,"activeCount":97},[],{"trials":3237,"activeCount":97},[],{"trials":3239,"activeCount":97},[],{"trials":3241,"activeCount":97},[],{"trials":3243,"activeCount":97},[],{"trials":3245,"activeCount":97},[3246],{"nctId":2842,"briefTitle":2843,"status":1011,"phases":3247,"primaryCompletion":2845,"completion":2845,"start":2846,"enrollment":799,"conditions":3248,"interventions":3249},[90],[2848],[2850,2851,2852,2853,2854,2855,2856,2857,2858,2817],{"intervention":3251,"totalTrials":93,"cells":3252},"Metvix cream",{"EARLY_PHASE1":3253,"PHASE1":3255,"PHASE2":3257,"PHASE3":3259,"PHASE4":3261,"NA":3263},{"trials":3254,"activeCount":97},[],{"trials":3256,"activeCount":97},[],{"trials":3258,"activeCount":97},[],{"trials":3260,"activeCount":97},[],{"trials":3262,"activeCount":97},[],{"trials":3264,"activeCount":97},[3265],{"nctId":3266,"briefTitle":3267,"status":306,"phases":3268,"primaryCompletion":3269,"completion":308,"start":3270,"enrollment":1328,"conditions":3271,"interventions":3274},"NCT05456334","New Treatments for Actinic Keratoses of the Scalp",[90],"2023-12-31","2016-03-24",[3272,3273],"Photodamaged Skin","Actinic Keratoses",[3251]]